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Chapter 1 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
Diabetes is a serious chronic disease which causes a high rate of morbidity and mortality all 
over the world. In 2007, more than 246 million people suffered from diabetes worldwide 
and unfortunately the incidence of diabetes is increasing at alarming rates. The number of 
people with diabetes is expected to double within the next 25 years due to a combination of 
population ageing, unhealthy diets, obesity and sedentary lifestyles. It can lead to blindness, 
heart disease, stroke, kidney failure, amputations and nerve damage. In women, diabetes 
can cause problems during pregnancy and make it more likely for the baby to be born with 
birth defects. Moreover, statistical analysis shows that 75% of diabetic patients die 
prematurely of cardiovascular disease (CVD). The absolute risk of cardiovascular disease in 
patients with type 1 (insulin-dependent) diabetes is lower than that in patients with type 2 
(non-insulin-dependent) diabetes, in part because of their younger age and the lower 
prevalence of CVD risk factors, and in part because of the different pathophysiology of the 
two diseases. Unfortunately, about 9 out of 10 people with diabetes have type 2 diabetes. 
For these reasons, cardiopathes and diabetic patients need to be frequently monitored and 
in some cases they could easily perform at home the requested physiological measurements 
(i.e. glycemia, heart rate, blood pressure, body weight, and so on) sending the measured 
data to the care staff in the hospital. Several researches have been presented over the last 
years to address these issues by means of digital communication systems. The largest part of 
such works uses a PC or complex hardware/software systems for this purpose. Beyond the 
cost of such systems, it should be noted that they can be quite accessible by relatively young 
people but the same does not hold for elderly patients more accustomed to traditional 
equipments for personal entertainment such as TV sets.  
 
Wearable devices can permit continuous cardiovascular monitoring both in clinical settings 
and at home. Benefits may be realized in the diagnosis and treatment of a number of major 
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diseases. In conjunction with appropriate alarm algorithms, they can increase surveillance 
capabilities for CVD catastrophe for high-risk subjects. Moreover, they could play an 
important role in the wireless surveillance of people during hazardous operations (military, 
fire-fighting, etc.) or during sport activities.  
 
For patients with chronic cardiovascular disease, such as heart failure, home monitoring 
employing wearable device and tele-home care systems may detect exacerbations in very 
early stages or at dangerous levels that necessitate an emergency room visit and an 
immediate hospital admission. 
 
Taking into account mains principles for the design of good wearable devices and friendly 
tele-home care systems, such as safety, compactness, motion and other disturbance 
rejection, data storage and transmission, low power consumption, no direct doctor 
supervision, it is imperative that these systems are easy to use and comfortable to wear for 
long periods of time.  
 
The aim of this work is to develop an easy to use tele-home care system for diabetes and 
cardiovascular monitoring, well exploitable even by elderly people, which are the main 
target of a telemedicine system, and wearable devices for long term measuring of some 
parameters related to sleep apnoea, heart attack, atrial fibrillation and deep vein 
thrombosis.  
 
Since set-top boxes for Digital Video Broadcast Terrestrial (DVB-T) are in simple computers 
with their Operating System, a Java Virtual Machine, a modem for the uplink connection and 
a set of standard ports for the interfacing with external devices, elderly, diabetics and 
cardiopathes could easily send their self-made exam to the care staff placed elsewhere. 
 
The wearable devices developed are based on the well known photopletysmographic 
method which uses a led source/detector pair applied on the skin in order to obtain a 
biomedical signal related to the volume and percentage of oxygen in blood. Such devices 
investigate the possibility to obtain more information to those usually obtained  by this 
technique (heart rate and percentage of oxygen saturation) in order to discover new 
algorithms for the continuous and remote or in ambulatory monitoring and screening of 
sleep apnoea, heart attack, atrial fibrillation and deep vein thrombosis. 
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Chapter 2 
 
Diabetes and Cardiovascular Diseases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diabetes is a serious metabolic disease which affects people of all ages and reduces both 
person’s quality of life and life expectancy. By 2025, the worldwide prevalence is projected 
to be 6.3 percent, a number very very high. The 65 percent of all deaths in developed 
countries are caused by cardiovascular disease of people with diabetes.  
 
Cardiovascular disease (CVD) is the number one cause of death worldwide [Mathers et al., 
2006; Murray et al., 1996]. It covers a wide array of disorders, including diseases of the 
cardiac muscle and of the vascular system supplying the heart, brain, and other vital organs.  
 
This chapter give a little review of diabetes and cardiovasclur diseases, starting from some 
aspect of diabetes and ending with an overview of the cardiovascular system, principles of 
electrocardiography, algorithms for automatic QRS detection, and a little overview of some 
diseases of cardiovascular system which are the main field of application of the devices and 
system developed in this thesis. 
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2.1 Diabetes 
Diabetes is a serious metabolic disease in which the body does not produce or properly use 
insulin [ADA, 2004]. Insulin is a naturally occurring hormone needed to transform sugar into 
energy required for daily life. 
Diabetes takes three major forms.  
• Type 1 diabetes results from destruction of the beta cells in the pancreas, leading to 
absolute insulin deficiency. It usually occurs in children and young adults and requires 
insulin treatment; 
• Type 2 diabetes, which accounts for approximately 85 to 95 percent of all diagnosed 
cases, is usually characterized by insulin resistance in which target tissues do not use 
insulin properly; 
• Gestational diabetes, is first recognized during pregnancy.  
Other rare types of diabetes include those caused by genetic conditions, surgery, drug use, 
malnutrition, infections, and other illnesses. 
 
The disease affects persons of all ages and reduces both a person’s quality of life and life 
expectancy and imposes a large economic burden on the health care system and on families. 
In 2003, the worldwide prevalence of diabetes was estimated at 5.1 percent among people 
age 20 to 79. By 2025, the worldwide prevalence is projected to be 6.3 percent, a 24 percent 
increase compared with 2003. The death rate of men with diabetes is 1.9 times the rate for 
men without diabetes, and the rate for women with diabetes is 2.6 times that for women 
without diabetes [Lee et al., 2000]. Premature mortality caused by diabetes results in an 
estimated 12 to 14 years of life lost [Manuel et al., 2004; Narayan et al., 2003]. 
Cardiovascular disease (CVD) causes up to 65 percent of all deaths in developed countries of 
people with diabetes [Geiss et al., 1995]. 
The World Health Organization (WHO) estimates that, in 2001, 959,000 deaths worldwide 
were caused by diabetes. More recent estimates by WHO suggest that the actual number 
may be triple this estimate [WHO, 2004]. 
 
2.1.1 Related Complications 
Diabetes-related complications include: 
• Microvascular diseases (e.g. retinopathy, blindness, nephropathy, and kidney 
failure); 
• Macrovascular diseases (coronary heart disease, stroke, peripheral vascular disease 
and lower-extremity amputation); 
• Influenza and pneumococcal infections; 
• Eye complications (e.g 39 percent of people with diabetes in India had eye-related 
complications [Rajala et al., 1998]). 
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Diabetes imposes large economic burdens on national health care systems and affects both 
national economies and individuals and their families.  
• Direct medical costs include resources used to treat the disease. They range from 2.5 
to 15.0 percent of annual health care budgets, depending on local prevalence and 
sophistication of the treatments available [IDF, 2003]; 
• Indirect costs include lost productivity caused by morbidity, disability, and premature 
mortality; 
• Intangible costs refer to the reduced quality of life for people with diabetes brought 
about by stress, pain, and anxiety. With a value of 1 representing the health-related 
quality of life without illness and 0 representing death, people with type 2 diabetes 
had a value of 0.77 in the population of the United Kingdom prospective diabetes 
study [Clarke et al., 2002]. 
 
2.1.2 Risk Factors 
Risk factors for diabetes vary by disease type: 
• Type 1 diabetes is most likely a polygenic disease, and a number of potential 
environmental risk factors have been implicated, including dietary factors, infectious 
agents, chemicals and toxins [Akerblom et al., 1998]; 
• The risk for type 2 diabetes is higher in monozygotic twins and people with a family 
history of diabetes [Rich, 1990]. This finding strongly suggests that genetic 
determinants play a role, but so far few genes have been associated with type 2 
diabetes. 
 
Environmental factors include [Qiao et al., 2004]: 
• Prenatal factors; 
• Obesity; 
• Physical inactivity; 
• Dietary; 
• Socioeconomic factors.  
Exposure to diabetes in utero increases the risk of developing type 2 diabetes in early 
adulthood [Dabelea et al., 2000].  
Sugar-sweetened beverages are associated with an increased risk of diabetes [Schulze et al., 
2004]. High intakes of dietary fiber and of vegetables may reduce the risk of diabetes [Fung 
et al., 2002; Stevens et al., 2002]. 
 
The strongest and most consistent risk factors for diabetes and insulin resistance among 
different populations are obesity and weight gain [Haffner, 1998]: for each unit increase in 
body mass index, the risk of diabetes increases by 12 percent [Ford et al., 1997]. The 
distribution of fat around the trunk region, or central obesity, is also a strong risk factor for 
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diabetes [Yajnik, 2001].  Therefore, diabetes risk may be reduced by increasing physical 
activity. Conversely, a sedentary lifestyle and physical inactivity are associated with 
increased risks of developing diabetes [Hu et al., 2003].  
 
2.1.3 Interventions and Delivery Modes 
Interventions against diabetes include those for: 
• preventing the disease; 
• detecting the disease in its asymptomatic stage; 
• managing the disease to reduce its complications. 
 
2.1.3.1 Preventing Type 1 Diabetes 
Not enough scientific evidence is available to indicate that type 1 diabetes can be prevented, 
although various interventions have been explored. Examples of tested interventions include 
eliminating or delaying exposure to bovine protein and using insulin or nicotinamide for 
people at high risk of developing the disease. 
 
2.1.3.2 Preventing Type 2 Diabetes 
Intensive lifestyle interventions involving a combination of diet and physical activity can 
delay or prevent diabetes among people at high risk [Eriksson et al., 1991; Knowler et al., 
2002; Pan et al., 1997; Tuomilehto et al., 2001]. 
 
2.1.3.3 Detecting Diabetes or Prediabetes  
The benefits of early detection of type 2 diabetes through screening are not clearly 
documented, nor is the choice of the appropriate screening test established. Questionnaires 
used alone tend to work poorly; biochemical tests alone or in combination with assessment 
of risk factors are a better alternative [Engelgau et al., 2000]. 
 
2.1.3.4 Managing Diabetes 
Short follow-up of self-management training on knowledge, frequency, and accuracy of self-
monitoring of blood glucose, self-reported dietary habits and glycemic control show high-
quality evidence of positive effects. 
 
2.1.4 Intensive Glucose Control 
The aim of intensive glucose control is to lower the glucose level of a person with diabetes to 
a level close to that of a person without diabetes. The U.K. Prospective Diabetes Study 
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clearly demonstrates that lowering glucose levels can prevent or delay long-term diabetes 
complications [UKPDS, 1998]. 
 
2.1.5 Diabetes Education 
People with diabetes play a central role in managing their disease. Thus, diabetes education 
is an integral part of diabetes care. The goal of diabetes education is to support the efforts 
of people with diabetes to understand the nature of their illness and its treatment, to 
identify emergency health problems at early, to adhere to self-care practices and to make 
necessary changes to their health habits [IDA, 2003].  
Moreover, diabetes self-management reduces medical costs for diabetes care in the short 
term. 
 
2.1.6 Quality of Diabetes Care 
The quality of diabetes care generally remains suboptimal worldwide, regardless of a 
particular country’s level of development, health care system, or population [Garfield et al., 
2003].  The Costs of Diabetes in Europe study, conducted in eight European countries, found 
suboptimal diabetes care in each country [Liebl et al., 2002]. In the United States, 
population-based surveys in the 1990s among adults age 18 to 75 with diabetes found that 
only 63 percent of them had had a dilated eye examination and only 55 percent had had a 
foot examination within the past year, 18 percent had poor glycemic control, 42 percent had 
good cholesterol control, and 66 percent had a blood pressure within the normal range 
[Saaddine et al., 2002]. 
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2.2 Cardiovascular Diseases 
 
2.2.1 Overview of Cardiovascular System 
2.2.1.1 The Heart 
The human heart is divided by a muscular wall into a right side and left side, each being one 
self-contained pumping station, but the two being connected in series (Fig. 2.1): 
• the left side of the heart drives oxygen-rich blood through the aortic semilunar outlet 
valve into the systemic circulation, which carries the blood to each cell in the body 
from which it returns to the right side of the heart poor in oxygen and rich in carbon 
dioxide [Tortora et al., 1993]; 
• the right side of the heart then drives this oxygen-poor blood through the pulmonary 
semilunar (pulmonic) outlet valve into the pulmonary circulation, which carries the 
blood to the lungs where its oxygen supply is replenished and its carbon dioxide 
content is purged before it returns to the left side of the heart.  
 
 
Figure 2.1: Anterior view of the human heart showing the four chambers, the inlet and outlet 
valves, the inlet and outlet major blood vessels, the wall separating the right side from the 
left side, and the two cardiac pacing centers (the sinoatrial node and the atrioventricular 
node) [Dorf et al., 2006]. 
 
Because of the anatomic proximity of the heart to the lungs, the right side of the heart does 
not have to work very hard to drive blood through the pulmonary circulation, so it functions 
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as a low-pressure (P ≤ 40 mmHg) compared with the left side of the heart, which does most 
of its work at a high pressure (up to 140 mmHg) to drive blood through the entire systemic 
circulation to the furthest extremes of the organism [Caro et al., 1978]. 
 
Each cardiac side is divided into two chambers: a small upper receiving chamber, or atrium, 
separated by a one-way valve from a lower discharging chamber, or ventricle, which is about 
twice the size of its corresponding atrium. In order of size, the left atrium is the smallest 
chamber of the entire heart, holding at rest about 45 ml of blood and operating at pressures 
on the order of 0 to 25 mmHg. The right atrium is next (63 ml of blood and 0 to 10 mmHg of 
pressure), followed by the left ventricle (100 ml of blood and up to 140 mmHg of pressure) 
and the right ventricle (about 130 ml of blood and up to 40 mmHg of pressure).  
 
During the filling phase (diastole), the inlet valves of the two ventricles (tricuspid valve from 
right atrium to right ventricle and bicuspid or mitral valve from left atrium to left ventricle) 
are open, and the outlet valves (pulmonary and aortic semilunar valve) are closed and the 
heart can expand to its end-diastolic-volume (EDV) [Kaley et al., 1977]. During the systole, 
electrically induced vigorous contraction of cardiac muscle drives the intraventricular 
pressure up, forcing the one-way inlet valves closed and the unidirectional outlet valves 
open as the heart contracts to its end-systolic-volume (ESV). Thus the ventricles normally 
empty about half their contained volume with each heart beat, the remainder being termed 
the cardiac reserve volume. The difference between the actual EDV and the actual ESV, 
called the stroke volume (SV), is the volume of blood expelled from the heart during each 
systolic interval. The ratio of SV to EDV is called the cardiac ejection ratio [Lentner, 1980]. If 
the stroke volume is multiplied by the number of systolic intervals per minute, or heart rate 
(HR), one obtains the total cardiac output (CO): 
 
    	
  
                                                                                                             (2.1) 
 
2.2.1.2 The Vascular System 
The vascular system is divided by a microscopic capillary (Fig. 2.2) network into an high-
pressure upstream viscoelastic tubes that carry blood away from the heart, and a low-
pressure downstream elastic conduits that return blood back to the heart. Except for their 
differences in thickness, the walls of the largest arteries and veins consist of the same three 
distinct, well-defined, and well-developed layers. These layers are: 
• the thinnest tunica intima, a continuous lining (the vascular endothelium) consisting 
of a single layer of simple squamous endothelial cells; 
• the thickest tunica media, composed of numerous circularly arranged elastic fibers, 
especially prevalent in the largest blood vessels on the arterial side (allowing them to 
expand during systole and to recoil passively during diastole); 
• the medium-sized tunica adventitia, consisting entirely of connective tissue. 
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The largest blood vessels, such as the aorta, the pulmonary artery, the pulmonary veins, 
and others, have such thick walls that they require a separate network of tiny blood vessels 
just to service the vascular tissue itself [Chandran et al., 1992]. The thick-walled large 
arteries and main distributing branches are designed to withstand the pulsating 80 to 130 
mmHg blood pressures that they must endure. The smaller elastic conducting vessels need 
only operate under steadier blood pressures in the range 70 to 90 mmHg, but they must be 
thin enough to penetrate and course through organs without unduly disturbing the anatomic 
integrity of the mass involved.  
 
 
Figure 2.2: The cardiac microscopic capillary network. 
 
It is not surprising that, at any given instant, about two-thirds of the total human blood 
volume residing in the venous system and the remaining one-third being divided among the 
heart (6.5%), the microcirculation (7% in systemic and pulmonary capillaries), and the 
arterial system (19.5 to 20%). 
 
Using an electrical analogy, one can think of the human cardiovascular system as a voltage 
source (the heart), two capacitors (a large venous system and a smaller arterial system), and 
a resistor (the microcirculation taken as a whole). Blood flow and the dynamics of the 
system represent electrical inductance, and useful engineering approximations can be 
derived from such a simple model.  
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2.2.1.3 The Conduction System 
The conductive system of the heart is composed of specialized fibers that can be subdivided 
into excitation and conduction fiber (Fig. 2.3). It consists of the sinoatrial (SA) node, 
intermodal tracks, Bachmann’s bundle, the atrioventricular (AV) node, the bundle of His, 
bundle branches and Purkinje fibers. Cardiac cells are able to depolarize at a rate specific for 
the cell type. The intrinsic rate of AV-nodal cells is about 50 beats per minute, whereas 
Purkinje fibers depolarize at a rate of no more than 40 bpm. During normal sinus rhythm, the 
heart is controlled by the SA node having the highest intrinsic rate of 60/100 bpm, 
depending on the hemodynamic demand. The right atrial internodal tracks and Bachmann’ s 
bundle conduct the SA-nodal activation throughout the atria, initiating a coordinated 
contraction of the atrial walls. Meanwhile, the impulse reaches the AV node, which is the 
only electrical connection between atria and ventricles. The AV node introduces an effective 
delay, allowing the contraction of the atria to complete before ventricular contraction is 
initiated. Due to this delay, an optimal ventricular filling is achieved. Subsequently, the 
electrical impulse is conducted at a high velocity by the His-Purkinje system comprising the 
bundle of His, bundle branches, and Purkinje fibers. Once the bundle of His is activated, the 
impulse splits into the right bundle branch, which leads to the right ventricle and the left 
bundle branch serving the left ventricle. Both bundle branches terminate in Purkinje fibers 
[Guyton et al., 1996].  
 
 
Figure 2.3: The cardiac conduction system. 
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2.2.1.4 Cardiovascular Control 
Control of cardiovascular function is accomplished by mechanisms that are based either on 
the inherent physicochemical attributes of the tissues and organs themselves (intrinsic 
control) or on responses that can be attributed to the effects on cardiovascular tissues of 
other organ systems in the body (extrinsic control). For example, the accumulation of 
wastes and depletion of oxygen and nutrients that accompany the increased rate of 
metabolism in an active tissue both lead to an intrinsic relaxation of local capillary with a 
consequent reduction of the local resistance to flow and thereby allows more blood to 
perfuse the active region. On the other hand, the extrinsic innervation by the autonomic 
nervous system of smooth muscle tissues in the walls of arterioles allows the central nervous 
system to completely shut down the flow to entire vascular beds when this becomes 
necessary (such as during exposure to extremely cold environments). In addition to 
controlling the distribution of blood, physiologic regulation of cardiovascular function is 
directed mainly at four other variables:  
• cardiac output; 
• blood pressure; 
• blood volume; 
 
Cardiac output can be increased by increasing the heart rate, increasing the end-diastolic 
volume, decreasing the end-systolic volume, or doing all three things at once. Under the 
extrinsic influence of the sympathetic nervous system, HR can triple, EDV can increase by as 
much as 50% and ESV can decrease a comparable amount to about 30 to 35 ml or less.  
 
The control of blood pressure is accomplished mainly by adjusting at the arteriolar level the 
downstream resistance to flow. This effect is conveniently quantified by a fluid-dynamic 
analogue to Ohm’s famous V = R*I law in electrotechnics theory. Voltage drop V being 
equated to fluid pressure drop P, electric current I corresponding to flow and electric 
resistance R being associated with an analogous vascular peripheral resistance.  
 
The control of blood volume is accomplished mainly through the excretory function of the 
kidney. For example, antidiuretic hormone secreted by the pituitary gland acts to prevent 
renal fluid loss and thus increases plasma volume, whereas perceived extracellular fluid 
overloads such as those which result from the peripheral vasoconstriction response to cold 
stress lead to a sympathetic receptor-induced renal diuresis (urination) that tends to 
decrease plasma volume to sometimes dangerously low dehydration levels.  
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2.2.1.5 Principles of Electrocardiography 
The electrocardiogram (ECG) is the recording on the body surface of the electrical activity 
generated by the heart (Fig. 2.4).  
 
Figure 2.4: Electrical activity generated by the heart. 
 
It was originally observed by Waller in 1889 [Waller, 1889] using his pet bulldog as the signal 
source and the capillary electrometer as the recording device. In 1903 Einthoven [Einthoven, 
1903] enhanced the technology by using the string galvanometer as the recording device 
and using human subjects with a variety of cardiac abnormalities. Einthoven is chiefly 
responsible for introducing some concepts still in use today including the labeling of the 
various waves, defining some of the standard recording sites, and developing the first 
theoretical construct whereby the heart is modeled as a single time-varying dipole.  
 
In order to record an ECG waveform, a differential recording between two points on the 
body are made. Traditionally each differential recording is referred to as a lead. Einthoven 
defined three leads numbered with the Roman numerals I, II, and III.  
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Figure 2.5: Einthoven leads. 
 
They are defined as: 
 
  
  
                                                                                                                                   (2.2) 
 
  
  
                                                                                                                                 (2.3) 
 
  
  
                                                                                                                                (2.4) 
 
                                                                                                                                            (2.5) 
 
where RA = right arm, LA = left arm, LL = left leg. Because the body is assumed to be purely 
resistive at ECG frequencies, the four limbs can be thought of as wires attached to the torso. 
Hence, lead I could be recorded from the respective shoulders without a loss of cardiac 
information. 
 
For 30 years the evolution of the ECG proceeded when Wilson [Wilson et al., 1934] added 
concepts of a unipolar recordings (Fig. 2.6). He created a reference point by tying the three 
limbs together and averaging their potentials so that individual recording sites on the limbs 
or chest surface would be differentially recorded with the same reference point.  
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Figure 2.6: Wilson’s central terminal and chest unipolar recordings. 
 
 
Figure 2.7: Goldberger’s augmented leads. 
 
Wilson extended the biophysical models to include the concept of the cardiac source 
enclosed within the volume conductor of the body. From the mid-1930s until today the 12 
leads composed of the 3 limb leads, 3 leads in which the limb potentials are referenced to a 
modified Wilson terminal [Goldberger, 1942] (the augmented leads (Fig. 2.7)), and 6 leads 
placed across the front of the chest and referenced to the Wilson terminal (Fig. 2.6) form the 
basis of the standard 12-lead ECG.  The voltage difference from any two sites will record an 
ECG, but it is these standardized sites with the massive 90-year collection of empirical 
observations that has firmly established their role as the standard. A typical ECG recording 
from lead II is shown in Fig. 2.8.  
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Figure 2.8: ECG lead II typical nomenclature. 
 
Einthoven chose the letters of the alphabet from P–U to label the waves and to avoid 
conflict with other physiologic waves being studied at the turn of the century. The ECG 
signals are typically in the range of 2mV and require a recording bandwidth of 0.05 to 100 
Hz. Full technical specification for ECG equipment has been proposed by both the American 
Heart Association [Bailey et al., 1990] and the Association for the Advancement of Medical 
Instrumentation [AAMI, 1993]. 
 
Other subsets of the 12-lead ECG are used in limited mode recording situations such as the 
tape-recorded ambulatory ECG (usually 2 leads) or in intensive care monitoring at the 
bedside (usually 1 or 2 leads) or telemetered within regions of the hospital from patients 
who are not confined to bed (1 lead). 
 
More recently the high resolution ECG has been developed whereby the digitized ECG is 
signal averaged to reduce random noise [Berbari et al., 1973; Berbari et al., 1977]. This 
approach, coupled with post-averaging high-pass filtering, is used to detect and quantify 
low-level signals (1.0 μV) not detectable with standard approaches.  
 
There are hundreds of interpretive statements from which a specific diagnosis is made for 
each ECG, but there are only about five or six major classification groups for which the ECG is 
used. The first step in analyzing an ECG requires the determination of the rate and rhythm 
for the atria and ventricles. Included here would be any conduction disturbances either in 
the relationship between the various chambers or within the chambers themselves. Then 
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one would proceed to identify features that would relate to the presence or absence of 
scarring due to a myocardial infarction. There may also be evidence of acute events 
occurring that would occur with ischemia or an evolving myocardial infarction.  
 
ECG signals may be corrupted by various kinds of noise. 
• power line interference; 
• electrode contact noise; 
• motion artifacts; 
• muscle contraction (electromyographic, EMG); 
• baseline drift and ECG amplitude modulation with respiration; 
• instrumentation noise generated by electronic devices used in signal processing; 
• electrosurgical noise, and other, less significant noise sources [l].  
 
Power line interference consists of 50/60 Hz pickup and harmonics which can be modeled as 
sinusoids and combination of sinusoids [2]. 
 
Electrode contact noise is transient interference caused by loss of contact between the 
electrode and skin, which effectively disconnects the measurement system from the subject. 
The loss of contact can be permanent, or can be intermittent, as would be the case when a 
loose electrode is brought in and out of contact with the skin as a result of movements and 
vibration. This switching action at the measurement system input can result in large artifacts 
since the ECG signal is usually coupled to the system. With the amplifier input disconnected, 
50 Hz interference may be significant. 
 
Motion artifacts are transient baseline changes caused by changes in the electrode-skin 
impedance with electrode motion. As this impedance changes, the ECG amplifier sees a 
different source impedance, which forms a voltage divider with the amplifier input 
impedance. Therefore, the amplifier input voltage depends on the source impedance, which 
changes as the electrode position changes. The usual cause of motion artifacts will be 
assumed to be vibrations or movement of the subject. The shape of the baseline disturbance 
caused by motion artifacts can be assumed to be a biphasic signal resembling one cycle of a 
sine wave. The peak amplitude and duration of the artifact are variables. 
 
Muscle contractions cause artifact potentials to be generated. The baseline ECG is usually in 
the microvolt range and therefore is usually insignificant. The signals resulting from muscle 
contraction can be assumed to be transient bursts of zero-mean band-limited Gaussian 
noise. The variance of the distribution may be estimated from the variance and duration of 
the bursts. 
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The drift of the baseline with respiration can be represented as a sinusoidal component at 
the frequency of respiration added to the ECG signal. The amplitude and frequency of the 
sinusoidal component should be variables. The amplitude of the ECG signal also varies by 
about 15% with respiration.  
 
When an ECG is corrupted by artifacts generated by electronic devices used in signal 
processing, the input amplifier has saturated and no information about the ECG can be 
reach. 
 
Electrosurgical noise completely destroys the ECG and can be represented by a large 
amplitude sinusoid with frequencies approximately between 100 kHz and 1 MHz. Since the 
sampling rate of an ECG signal is 250 to 1000 Hz, an aliased version of this signal would be 
added to the ECG signal. The amplitude, duration, and possibly the aliased frequency should 
be variable. 
 
2.2.1.6 QRS Detection 
The QRS complex is the most striking waveform within the electrocardiogram. Since it 
reflects the electrical activity within the heart during the ventricular contraction, the time of 
its occurrence as well as its shape provide much information about the current state of the 
heart. Moreover, it serves as the basis for the automated determination of the heart rate, as 
an entry point for classification schemes of the cardiac cycle, and often it is also used in ECG 
data compression algorithms. In that sense, QRS detection provides the fundamentals for 
almost all automated ECG analysis algorithms. 
 
Software QRS detection has been a research topic for more than 30 years. Within the last 
decade many new approaches to QRS detection have been proposed, such as algorithms 
from the field of artificial neural networks [Hu et al., 1993; Strintzis et al., 1992; Vijaya et al., 
1998; Xue et al., 1992], genetic algorithms [Poli et al., 1995], wavelet transforms [Kadambe 
et al., 1999; Li et al., 1995; Bahoura et al., 1997; Cellar et al., 1997; Crowe et al., 1992] and 
filter banks [Afonso et al., 1999]. 
 
Typical frequency components of a QRS complex range from about 10 Hz to about 25 Hz. 
Therefore, almost all QRS detection algorithms use a filter stage prior to the actual detection 
stage in order to attenuate other signal components and artifacts, such as P-wave, T-wave, 
baseline drift, and coupling noise (Fig. 2.9).  
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Figure 2.9: Common structure of the QRS detectors. 
 
Whereas the attenuation of the P- and T-wave as well as baseline drift requires high-pass 
filtering, the suppression of coupling noise is usually accomplished by a low-pass filter. The 
combination of low and high pass means effectively the application of a band-pass filter, in 
this case with cut-off frequencies at about 10 Hz and 25 Hz. 
 
2.2.1.6.1 Algorithms Based on Amplitude and First Derivative 
Let , ,… ,  represent a one-dimensional array of sample points of the 
synthesized digitized ECG. 
 
A1: Moriet-Mahoudeaux [Mahoudeaux et al., 1981]. 
An amplitude threshold is calculated as a fraction of the largest positive valued element of 
that array: 
 
. . .    !"#$      &'(       ) * ) 8191                                                         (2.6) 
 
The first derivative .# is calculated at each point of # such that  
 
.#  #     #       &'(       ) * ) 819                                                           (2.7) 
 
A QRS candidate occurs when three consecutive points in the first derivative array exceed a 
positive slope threshold and are followed within the next 100ms by two consecutive points 
which exceed the negative threshold. All data points in the ECG between the onset of the 
rising slope and before the end of the descending slope must meet or exceed the amplitude 
threshold. 
 
./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, ./  0 1 0.5                                                                                                     (2.8) 
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/, /  ,… , 4   = . .                                                                                  (2.10) 
 
A2: Fraden-Neuman [Fraden et al., 1988]. 
A threshold is calculated as a fraction of the peak value of the ECG. 
 
. . . >   !"#$      &'(       ) * ) 8191                                                       (2.11) 
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 ) 0     &'(       ) * ) 819                                                           (2.13) 
 
.#  .# :& .# = . .                                                                                       (2.14) 
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The first derivative is calculated at each point of the clipped, rectified array: 
 
.0#  .#    .#       &'(       ) * ) 819                                                 (2.16) 
 
A QRS candidate occurs when a point in Y 2 ( n ) exceeds the fixed constant threshold: 
 
.0/ 1 0.7                                                                                                                                      (2.17) 
 
A3: Gustafson [Gustafson et al., 1977]. 
The first derivative is calculated at each point of the ECG: 
 
.#  #     #       &'(       ) * ) 819                                                        (2.18) 
 
The first derivative array is then searched for points which exceed a constant threshold: 
 
./  = . D                                                                                                                                    (2.19) 
 
Then the next three derivative values ./  , ./  0, ./   must also exceed . D. 
If the above conditions are met, point i can be classified as a QRS candidate if the next two 
sample points have positive slope amplitude products: 
 
./  /  E#F ./  0/  0 1 0                                                                           (2.20) 
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2.2.1.6.2 Algorithms Based on First Derivative Only 
B1: Menard [Menard et al., 1981]. 
The first derivative is calculated for each point of the ECG, using the formula specified by: 
 
.#   0#  0  #    #    0#  0    &'(     0 ) * ) 81     (2.21) 
 
The slope threshold is calculated as a fraction of the maximum slope for the first derivative 
array.  
 
GHI. . J   !".#$      &'(      0 ) * ) 81                                                      (2.22) 
 
The first derivative array was searched for points which exceed the slope threshold. The first 
point that exceeds the slope threshold is taken as the onset of a QRS candidate: 
 
./ 1 KL'A8.                                                                                                                             (2.23) 
 
B2: Holsinger [Holsinger et al., 1971]. 
The first derivative is calculated for the ECG: 
 
.#  #     #       &'(       ) * ) 819                                                        (2.24) 
 
This array is searched until a point is found that exceeds the slope threshold: 
 
./ 1 0.45                                                                                                                                      (2.25) 
 
A QRS candidate occurs if another point in the next three sample points also exceeds the 
threshold: 
 
./   1 0.45                                                                                                                              (2.26) 
 
or 
 
./  0 1 0.45                                                                                                                              (2.27) 
 
or 
 
./   1 0.45                                                                                                                              (2.28) 
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2.2.1.6.3 Algorithms Based on First and Second Derivative 
 
C1: Balda [Balda et al., 1977]. 
The absolute values of the first and second derivative are calculated from the ECG: 
 
.#  ENO"#    #  $     &'(      0 ) * ) 81                                            (2.29) 
 
.#  ENO"#  0  0#  #  0$     &'(      0 ) * ) 81                           (2.30) 
 
These two arrays are scaled and then summed: 
 
.0#  . .#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     &'(      0 ) * ) 81                                                     (2.31) 
 
This array is scanned until a threshold is met or exceeded: 
 
.0/ = .                                                                                                                                      (2.32) 
 
Once this occurs, the next eight points are compared to the threshold. If six or more of these 
eight points meet or exceed the threshold, the criteria for identification of a QRS candidate 
is met. 
 
C2: Ahlstrom-Tompkins [Ahlstrom et al., 1983]. 
The rectified first derivative is calculated from the ECG: 
 
.#  ENO"#    #  $     &'(       ) * ) 81                                            (2.33) 
 
The rectified first derivative is then smoothed: 
 
.#  .#P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Q.#Q>      &'(       ) * ) 81                                                      (2.34) 
 
The rectified second derivative is calculated: 
 
.0#  ENO"#  0  0#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$     &'(       ) * ) 81                           (2.35) 
 
The rectified, smoothed first derivative is added to the rectified second derivative: 
 
.#  .#  .0#     &'(       ) * ) 81                                                                   (2.36) 
 
The maximum value of this array is determined and scaled to serve as primary and 
secondary thresholds: 
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$      &'(       ) * ) 81                                             (2.37) 
 
ITH#FES.. .    !".#$      &'(       ) * ) 81                                         (2.38) 
 
The array of the summed first and second derivatives is scanned until a point exceeds the 
primary threshold. In order to be classified as a QRS candidate, the next six consecutive 
points must all meet or exceed the secondary threshold: 
 
./ = RS/ES..                                                                                                                   (2.39) 
 
and  
 
./  , ./  0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2.2.1.6.4 Algorithms Based on Digital Filters 
 
D1: Engelese-Zeelenberg [Engelese et al., 1979]. 
The ECG is passed through a differentiator with a 62.5 Hz notch filter. 
 
.#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The differentiated, filtered data is then passed through a digital low-pass filter. 
 
.#  .#  >.# 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                      (2.42) 
 
Two thresholds are used, equal in magnitude but opposite in polarity. The output of the low-
pass filter is scanned until a point with amplitude greater than the positive threshold is 
reached. This point is the onset of a 160ms search region. The number of alternate threshold 
crossings is used to classify the initial crossing as either a baseline shift, a QRS candidate, or 
as noise: 
 
Z& ./ 1 21.0, [78* OIEST SI\/H# H#OI]  /                                                                (2.43) 
 
If no other threshold crossings occur within the 160ms search region, the occurrence is 
classified as a baseline shift. Otherwise, the following three conditions are tested: 
 
1 Z& ./  4 ) 21.0     &'(       ) 9 ) 40                                                                         (2.44) 
 
2 Z& ./  4 ) 21.0     &'(       ) 9 ) 40                                                                         (2.45) 
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and 
 
.  ^ 1 21.0     &'(      4 ) _ ) 40                                                                                     (2.46) 
 
3 Z& ./  4 ) 21.0     &'(       ) 9 ) 40                                                                         (2.47) 
 
and 
 
./  ^ 1 21.0     &'(      4 ) _ ) 40                                                                                      (2.48) 
 
and 
 
./   ) 21.0     &'(      ^ ) 1 ) 40                                                                                 (2.49) 
 
If any of the above conditions apply, the occurrence is classified as a QRS candidate. If 
additional threshold crossings occur, the occurrence is classified as noise. 
 
D2: Okada [Okada, 1979]. 
The first stage smooths the ECG using a three-point moving average filter: 
 
.#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The output of the moving averaging filter is passed through a low-pass filter. 
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The difference between the input and output of the lowpass filter is squared: 
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The squared difference is filtered: 
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A fourth array is formed using the following formula: 
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The maximum value of this array is determined and scaled to form the threshold: 
 
. . 0D   !".>#$      &'(       ) * )                                              (2.55) 
 
A QRS candidate occurs when a point in Y 4 ( n ) exceeds the threshold: 
 
Z& .># 1 B7.     [78*       e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Okada suggests setting m equal to three for best results. However, it was determined using 
the tuning procedure that larger values of m result in improved performance for several 
types of noise.  
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2.2.2 Sleep Apnoea 
Sleep Apnoea (SA) is a common sleep disorder characterized by brief interruptions of 
breathing during sleep, with an estimated prevalence of about 4% in men and 2% in women 
[Young et al., 1993]. It can cause a total blockage of throat’s airway (i.e. apnoea) or a partial 
blockage of the airway which reduces the amount of oxygen that is taken into the body by 
50% (i.e. hypopnoea). The amount of time in which a person stops breathing during the 
sleep is usually 10 seconds or longer and sometimes for as long as a minute [Shahar et al., 
1991]. 
 
There are two major forms of SA:  
• Obstructive Sleep Apnoea (OSA); 
• Central Sleep Apnoea (CSA). 
 
Obstructive apnoeas and hypopnoeas result from complete or partial collapse of a narrowed 
pharynx during sleep [Bradley et al., 1986] (Fig. 2.10).  
 
Figure 2.10: Obstructive apnoea. 
 
In subjects with normal pharyngeal anatomy, the partial withdrawal of pharyngeal dilator 
muscle tone that accompanies the onset of sleep is insufficient to cause pharyngeal collapse. 
However, the pharynx of patients with OSA is anatomically narrowed and highly compliant. 
In this setting, the superimposition of the normal withdrawal of pharyngeal dilator muscle 
tone at sleep onset causes the pharynx to occlude, triggering apnoea or hypopnoea 
[Remmers et al., 1978]. 
 
Treatments for obstructive sleep apnoea include Continuous Positive Airway Pressure 
(CPAP), a machine that delivers air pressure through a mask placed over the nose while 
sleeping (Fig. 2.11). With CPAP, the air pressure is somewhat greater than that of the 
surrounding air, and is just enough to keep upper airways passages open, preventing apnoea 
and snoring.  
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Figure 2.11: Continuous Positive Airway Pressure for Obstructive Apnoea Treatment. 
 
Central Sleep Apnoea, commonly referred to as Cheyne-Stokes respiration, is a form of 
periodic breathing in witch apnoeas and hypopnoeas alternate with periods of 
hyperventilation. It is usually initiated during sleep by a further acute increase in ventilation 
and reduction in arterial carbon dioxide pressure (PaCO2) because the brain fails to send the 
appropriate signals to the breathing muscles to initiate respiration [Naughton et al., 1993]. 
When PaCO2 falls below the threshold level required to stimulate breathing, the central 
drive to respiratory muscles and airflow stop, and central apnoea ensues [Bradley et al., 
1992]. 
 
SA is associated with a wide range of health implications and increased cardiovascular 
diseases and mortality. It has been linked to depression, irritability, sexual dysfunction, 
learning and memory difficulties, high blood pressure (hypertension), heart attack and 
stroke. At least 50% of patients with heart failure have OSA or CSA, responsible to the 
adverse consequences of the cardiovascular system [Sin et al., 1999]. It is important to 
notice that the effects of sleep apnoea on the cardiovascular system are not confined to 
sleep. Daytime sympathetic nervous activity and blood pressure, in fact, are increased in 
patients with OSA [Somers et al., 1995]. A continuous screening of sleep apnoea disorder is 
needed in order to have a major benefit of the treatment on cardiovascular outcomes. 
 
The gold standard in diagnosing of SA is overnight polysomnography (PSG) (Fig. 2.12). It uses 
non-invasive methods for the recording of various physiological parameters including EEG, 
ECG, EMG, nasal airflow, abdominal and thoracic movements and blood oxygen saturation 
(SpO2) [Haponik et al., 1984]. 
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Figure 2.12: Overnight Polysomnography. 
 
Fig. 2.12 shows that as a result of sleep apnoea, the oxygen level in the bloodstream falls 
and carbon dioxide which is a waste product of the body's chemical processes, accumulates. 
After a while the changes in these two chemicals in the bloodstream stimulate breathing 
again and the patient starts to make respiratory efforts. 
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2.2.3 Atrial Fibrillation 
Atrial Fibrillation (AF) is a supraventricular arrhythmia characterized by uncoordinated atrial 
activation with consequent deterioration of atrial mechanical function [Fuster et al., 2001]. 
An arrhythmia is a problem with the speed or rhythm of the heartbeat. AF occurs when 
rapid, disorganized electrical signals in the heart’s two upper chambers cause them to 
contract very fast and irregularly (Fig. 2.13). As a result, blood pools in the atria and isn’t 
pumped completely into the heart’s two lower chambers (ventricles). When this happens, 
the heart’s upper and lower chambers don’t work together as they should [Wyse et al., 
2002]. 
 
 
Figure 2.13: Comparison between a normal conduction and atrial fibrillation. 
 
There are three types of atrial classification: 
• paroxysmal atrial fibrillation: the abnormal electrical signals and rapid heart rate 
begin suddenly and then stop on their own; 
• persistent atrial fibrillation:  the abnormal heart rhythm continues until it is stopped 
with treatment; 
• permanent atrial fibrillation: the normal heart rhythm cannot be restored with the 
usual treatments; 
Both paroxysmal and persistent atrial fibrillation may become more frequent and eventually 
result in permanent AF.  
 
On the electrocardiogram, AF is described by the replacement of consistent P waves by rapid 
oscillations that vary in size, shape, and timing, associated with an irregular, frequently rapid 
ventricular response [Fuster et al., 2001] (Fig. 2.14).  
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Figure 2.14: Atrial fibrillation events in a ECG recording. 
 
AF can be isolated or associated with other arrhythmias, often atrial flutter or atrial 
tachycardia. Atrial flutter can arise during treatment with antiarrhythmic agents prescribed 
to prevent recurrent AF. Untreated, the atrial rate typically ranges from 240 to 320 beats per 
minute (bpm).  
 
The clinical risk factors for AF include advancing age, diabetes, hypertension, congestive 
heart failure, rheumatic and nonrheumatic valve disease, myocardial infarction and stroke 
[Capucci et al., 1995]. In fact, during AF, the atria don’t pump all of their blood to the 
ventricles and some blood may pools in the atria. When this happens, a blood clot (a 
thrombus) can form. If the clot breaks off and travels to the brain, it can cause a stroke    
(Fig. 2.15).  
 
Figure 2.15: Stroke caused by a clot due to atrial fibrillation disease. 
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2.2.4 Deep Vein Thrombosis and Pulmonary 
Embolism 
Thrombosis is the formation of blood clots within blood vessels. Deep Vein Thrombosis 
(DVT) is a blood clot that forms in a vein deep in the body [Abelsethe et al., 1996]. Most 
deep vein blood clots occur in the lower leg but they also can occur in other parts of the 
body (brachial vein, radial vein, ulnar vein, femoral vein, popliteal vein, peroneal vein, 
anterior tibial vein, posterior tibial vein). 
 
 
Figure 2.16: A deep vein clot in femoral vein. 
 
A DVT can occur without symptoms, but in many cases the affected extremity will be painful, 
swollen, red, warm and the superficial veins may be engorged [Levenson et al., 1990]. 
 
The gold standard in treatment of DVT is Oral Anticoagulant Therapy (OAT), also called blood 
thinner. OAT decrease the blood's ability to clot or also stop existing blood clots from getting 
bigger. However, blood thinners can't break up blood clots that have already formed (the 
body dissolves most blood clots with time). Warfarin and heparin are two blood thinners 
used to treat DVT. Warfarin is given in pill form. Heparin is given as an injection [Kazmier, 
1992].  
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The most common side effect of blood thinners is bleeding. This happens if the medicine 
thins the blood too much. People treated with blood thinners usually use regular blood tests 
to measure their blood's ability to clot. These blood tests are called PT (Prothrombin Time) 
tests (Fig. 2.17). 
 
  
Figure 2.17: Automatic measurement of PT. 
 
These tests help the doctor make sure the patient is taking the right amount of medicine.  
 
Blood clots can form in deep veins when: 
• damage occurs to a vein's inner lining. This damage may result from injuries caused 
by physical, chemical, and biological factors. Such factors include surgery, serious 
injury, inflammation, or an immune response; 
• blood flow is sluggish or slow. Lack of motion can cause sluggish or slowed blood 
flow. This may be caused after surgery,  by illnesses and in bed or travelling for a long 
time;  
• the blood is thicker or more likely to clot than usual. Certain inherited conditions 
(such as the genetic factor V Leiden), treatment with hormone replacement therapy 
or using birth control pills, increase blood's tendency to clot. 
 
A blood clot in a deep vein can break off and travel through the bloodstream. The loose clot 
is called an embolus. When the clot travels to the lungs and blocks blood flow, the condition 
is called Pulmonary Embolism (PE) (Fig. 2.18) [Tsai et al., 2002].  
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Figure 2.18: Pulmunary embolism. 
 
PE is a serious condition that can cause: 
• permanent damage to part of lungs from lack of blood flow to lung tissue; 
• low oxygen levels in blood;  
• damage to other organs in from not getting enough oxygen; 
• death. 
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2.2.5 Myocardial infarction or Heart Attack 
Myocardial infarction (MI), commonly known as a heart attack (HA), occurs when the blood 
supply to part of the heart is interrupted [AHA, 2006]. This is most commonly due to 
occlusion (blockage) of a coronary artery (Fig. 2.19). 
 
 
Figure 2.19: Heart Attack caused by the occlusion of the coronary artery. 
 
The resulting restriction in blood supply (ischemia) and oxygen shortage, if left untreated for 
a sufficient period, can cause damage and/or death (infarction) of heart muscle tissue. Heart 
attacks are the leading cause of death for both men and women all over the world [WHO, 
2004]. 
 
Classical symptoms of acute myocardial infarction include sudden chest pain (typically 
radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting, 
palpitations, sweating, and anxiety. Women may experience fewer typical symptoms than 
men, most commonly shortness of breath, weakness, a feeling of indigestion, and fatigue 
[Kosuge et al., 2006]. Approximately one quarter of all myocardial infarctions are silent, 
without chest pain or other symptoms.  
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Important risk factors are previous cardiovascular disease (such as angina, a previous heart 
attack or stroke), older age (especially men over 40 and women over 50), tobacco smoking, 
high blood levels of certain lipids (triglycerides, low-density lipoprotein or "bad cholesterol") 
and low high density lipoprotein (HDL, "good cholesterol"), diabetes, high blood pressure, 
obesity, chronic kidney disease, heart failure, excessive alcohol consumption, the abuse of 
certain drugs (such as cocaine), and chronic high stress levels [D’Aiuto et al., 2006]. 
Immediate treatment for suspected acute myocardial infarction includes oxygen, aspirin, 
and sublingual glyceryl trinitrate (nitroglycerin) [Pearson et al., 2003]. The patient will 
receive a number of diagnostic tests, such as an electrocardiogram, a chest X-ray and blood 
tests to detect heart muscle damage. In patients who have multiple blockages and who are 
relatively stable bypass surgery of the blocked coronary artery is an option. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
49 
 
Chapter 3 
 
Introduction to Signal Processing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biomedical signals, like all the other electronic signals related to a phenomenon of interest, 
need to be processed in some ways in order to remove noise and in order to extract useful 
information carried by electronic waveforms. 
 
This chapter give an introduction to digital signal processing, starting from basic concept of 
noise, Fourier transform, and ending with a brief overview of digital filters. Such techniques 
era used in deep in all hardware and software developed in this thesis. 
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3.1 Noise and Random Variables 
Noise is an inherent component of most measurements. In addition to physiological and 
environmental noise, electronic noise arises from the transducer and associated electronics 
and is intermixed with the signal being measured. It is usually represented as a random 
variable, x(n). Since the variable is random, describing it as a function of time is not very 
useful. It is more common to discuss other properties of noise such as its probability 
distribution, range of variability, or frequency characteristics. While noise can take on a 
variety of different probability distributions, the central limit theorem implies that most 
noise will have a Gaussian or normal distribution. The central limit theorem states that when 
noise is generated by a large number of independent sources it will have a Gaussian 
probability distribution regardless of the probability distribution characteristics of the 
individual sources. The probability of a Gaussianly distributed variable, is specified in the 
well-known normal or Gaussian distribution equation: 
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Two important properties of a random variable are its mean, or average value, and its 
variance. The mean value of a discrete vector is evaluated as: 
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The sample variance k0, is calculated as shown below, and the standard deviation σ, is just 
the square root of the variance. 
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When multiple measurements are made, multiple random variables can be generated. If 
these variables are combined or added together, the means add so that the resultant 
random variable is simply the mean, or average, of the individual means. The same is true 
for the variance. 
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However, the standard deviation is the square root of the variance and the standard 
deviations add as the √z times the average standard deviation. Accordingly, the mean 
standard deviation is the average of the individual standard deviations divided by √z. 
 
∑ ft  j^a √jfi0  √jfi                                                                                                               (3.6) 
 
In other words, averaging noise from different sensors, or multiple observations from the 
same source, will reduce the standard deviation of the noise by the square root of the 
number of averages.  
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MSD indicates that averaging can be a simple, yet powerful signal processing technique for 
reducing noise when multiple observations of the signal are possible. Such multiple 
observations could come from multiple sensors, but in many biomedical applications, the 
multiple observations come from repeated responses to the same stimulus. In ensemble 
averaging, a group of time responses are averaged together on a point-by-point basis and an 
average signal is constructed by taking the average, for each point in time, over all signals in 
the ensemble. Two essential requirements for the application of ensemble averaging for 
noise reduction are needed: multiple observations, and a reference signal closely to the 
response. 
 
3.2 Transforms 
In signal processing there are waveforms, images and entities that operate on waveforms or 
images [Hubbard, 1998]. The entities can be functions that modify the data and functions 
used to analyze or probe the data. Functions that modify data are also termed operations 
or transformations. A transform can be thought of as a re-mapping of the original data into a 
function that provides more information than the original.  
 
Many of the common transforms are achieved by comparing the signal of interest with some 
sort of probing function. This comparison takes the form of a correlation (produced by 
multiplication) that is averaged (or integrated) over the duration of the waveform, or some 
portion of the waveform: 
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where x(t) is the waveform being analyzed, fm(t) is the probing function (the basis) and m is 
some variable of the probing function, often specifying a particular member in a family of 
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similar functions. For example, in the Fourier Transform fm(t) is a family of harmonically 
related sinusoids and m specifies the frequency of an individual sinusoid in that family.  
 
Since most signal processing operations are implemented using digital electronics, functions 
are represented in discrete form as a sequence of numbers: 
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and the integral becomes summation over a finite range: 
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where fm(n) is a discrete version of the family of probing functions. 
  
When either x(t) or fm(t) are of infinite length, they must be truncated to fit within the 
confines of limited memory storage. The length of either function can be shortened by 
simple truncation or by multiplying the function by yet another function that has zero value 
beyond the desired length. A function used to shorten another function is termed a window 
function, and its action is shown in Fig. 3.1.  
 
 
Figure 3.1: A waveform (upper plot) is multiplied by a window function (middle plot) to 
create a truncated version of the original waveform (lower plot). 
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Figure 3.2: The most popular windows function in signal processing. 
 
Simple truncation can be viewed as multiplying the function by a rectangular window, a 
function whose value is one for the portion of the function that is retained, and zero 
elsewhere. The consequences of this artificial shortening will depend on the specific window 
function used.  
 
If a window function is used, Eq. (3.10) becomes: 
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where W(n) is the window function.  
 
If the probing function is of finite length (have finite support) and this length is shorter than 
the waveform, then it might be appropriate to translate or slide it over the signal and 
perform the comparison (correlation, or multiplication) at various relative positions between 
the waveform and probing function. This sliding comparison is given in discrete form by the 
equation: 
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where the variable k indicates the relative position between the two functions. This 
approach is adopted in the filters used in the Continuous Wavelet Transform. 
 
A variation of this approach can be used for long probing functions, where the probing 
function is shortened by windowing to a length that is less than the waveform. Then the 
shortened probing function can be translated across the waveform in the same manner as a 
probing function that is naturally short. The equation for this condition becomes: 
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where fm(n) is a longer function that is shortened by the sliding window function W(n − k). 
This is the approach taken in the Short-Term Fourier Transform. 
 
3.3 Convolution, Correlation and Covariance 
Convolution is an important concept in linear systems theory, solving the need for a time 
domain operation equivalent to the Transfer Function. Transfer Function is a frequency 
domain concept that is used to calculate the output of a linear system to any input. 
Convolution can be used to define a general input–output relationship in the time domain 
analogous to the Transfer Function in the frequency domain.  
 
 
 
 
The input x(t), the output y(t), and the function linking the two through convolution h(t), are 
all functions of time. Hence, convolution is a time domain operation.  
 
The basic concept behind convolution is superposition. The first step is to determine a time 
function h(t) that tells how the system responds to an infinitely short segment of the input 
waveform. If superposition holds, then the output can be determined by summing 
(integrating) all the response contributions calculated from the short segments. The way in 
which a linear system responds to an infinitely short segment of data can be determined 
simply by noting the system’s response to an infinitely short input δ(t). 
 
Given that the impulse response describes the response of the system to an infinitely short 
segment of data, and any input can be viewed as an infinite string of such infinitesimal 
segments, the impulse response can be used to determine the output of the system to any 
input. The response produced by an infinitely small data segment is simply this impulse 
response scaled by the magnitude of that data segment. The contribution of each infinitely 
small segment can be summed, or integrated, to find the response created by all the 
segments.  
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To determine the impulse of each infinitely small data segment, the impulse response is 
shifted a time τ with respect to the input, then scaled (i.e., multiplied) by the magnitude of 
the input at that point in time.  
y(t) x(t) 
h(t) 
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For most systems h(τ) is finite, so the limit of integration is finite. Moreover, a real system 
can only respond to past inputs, so h(τ) must be 0 for τ < 0 (negative τ implies future times 
in Eq. (3.14), although for computer-based operations, where future data may be available in 
memory, τ can be negative. 
 
For discrete signals, the integration becomes a summation and the convolution equation 
becomes: 
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Correlation and Covariance connote similarity: how one thing is like another. 
Mathematically, correlations are obtained by multiplying and normalizing. Both covariance 
and correlation use multiplication to compare the linear relationship between two variables, 
but in correlation the coefficients are normalized to fall between zero and one. This makes 
the correlation coefficients insensitive to variations in the gain of the data acquisition 
process or the scaling of the variables. The operations of correlation and covariance can be 
applied to two or more waveforms, to multiple observations of the same source, or to 
multiple segments of the same waveform. 
Correlation and covariance operations can not only be used to compare different waveforms 
at specific points in time, they can also make comparisons over a range of times by shifting 
one signal with respect the other. The crosscorrelation function is an example of this 
process. The correlation function is the lagged product of two waveforms, and the defining 
equation, given here in both continuous and discrete form, is quite similar to the 
convolution equation: 
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These equations show that the only difference in the computation of the crosscorrelation 
versus convolution is the direction of the shift. In convolution the waveforms are shifted in 
opposite directions. This produces a causal output: the output function is the creation of 
past values of the input function.  
Crosscorrelation shows the similarity between two waveforms at all possible relative 
positions of one waveform with respect to the other, and it is useful in identifying segments 
of similarity. A special case of the correlation function occurs when the comparison is 
between two waveforms that are one in the same. This is termed the autocorrelation 
function and it provides a description of how similar a waveform is to itself at various time 
lags. The autocorrelation function will naturally be maximum for zero lag (n = 0) because at 
zero lag the comparison is between identical waveforms. Usually the autocorrelation is 
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scaled so that the correlation at zero lag is 1. The function must be symmetric about n = 0, 
since shifting one version of the same waveform in the negative direction is the same as 
shifting the other version in the positive direction. 
 
The autocorrelation function is related to the bandwidth of the waveform. The sharper the 
peak of the autocorrelation function the broader the bandwidth. For example, in white 
noise, which has infinite bandwidth, adjacent points are uncorrelated, and the 
autocorrelation function will be nonzero only for zero lag. 
 
 
Figure 3.3: Autocorrelation of two colored noise with different bandwidths. 
 
The crosscovariance function is the same as crosscorrelation function except that the means 
have been removed from the data before calculation. Accordingly, the equation is a slight 
modification of Eq. (3.17), as shown below: 
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The terms correlation and covariance, when used alone (i.e., without the term function), 
imply operations similar to those described in Eqs. (16) and (17), but without the lag 
operation. The result will be a single number.  
Of particular interest is the covariance and correlation matrices. These analysis tools can be 
applied to multivariate data where multiple responses, or observations, are obtained from a 
single process. The covariance and correlation matrices assume that the multivariate data 
are arranged in a matrix where the columns are different variables and the rows are 
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different observations of those variables. In signal processing, the rows are the waveform 
time samples, and the columns are the different signal channels or observations of the 
signal. Since the diagonals in the correlation matrix give the correlation of a given variable or 
waveform with itself, they will all equal to 1, and the off-diagonals will vary between ± 1. In 
its usual signal processing definition, the correlation matrix is a normalized version of the 
covariance matrix.  
 
3.4 Fourier Analysis 
Sometimes the frequency content of the waveform provides more useful information than 
the time domain representation. The accurate determination of the waveform’s spectrum 
requires that the signal be periodic, or of infinite length, and noise-free. The problem is that 
in many biological applications only a portion of the waveform is available for analysis. 
Moreover, biosignals are often corrupted by substantial amounts of noise or artifact. If only 
a portion of the actual signal can be analyzed, and/or if the waveform contains noise along 
with the signal, then all spectral analysis techniques must necessarily be approximate. The 
various spectral analysis approaches attempt to improve the estimation accuracy of specific 
spectral features. 
 
The Fourier transform approach takes advantage of the fact that sinusoids contain energy at 
only one frequency. If a waveform can be broken down into a series of sines or cosines of 
different frequencies, the amplitude of these sinusoids must be proportional to the 
frequency component contained in the waveform at those frequencies [Boashash, 1992]. 
From Fourier series analysis, we know that any periodic waveform can be represented by a 
series of sinusoids that are at the same frequency as, or multiples of, the waveform 
frequency. This family of sinusoids can be expressed either as sines and cosines, each of 
appropriate amplitude, or as a single sine wave of appropriate amplitude and phase angle. 
Expressed as an equation, this procedure becomes: 
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where T is the period of the waveform and m is set of integers, possibly infinite. This gives 
rise to a family of sines and cosines having harmonically related frequencies (

 ). 
 
Since this approach represents waveforms by harmonically related sinusoids, the approach is 
sometimes referred to as harmonic decomposition. For periodic functions, the Fourier 
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transform and Fourier series constitute a bilateral transform: the series of sine and cosine 
components can be summed to reconstruct the original waveform: 
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Spectral information is usually presented as a frequency plot, a plot of sine and cosine 
amplitude versus component number, or the equivalent frequency. Rather than plot sine 
and cosine amplitudes, it is more intuitive to plot the amplitude and phase angle of a 
sinusoidal wave using the rectangular-to-polar transformation. 
Some waveforms are symmetrical or anti-symmetrical about t = 0, so that one or the other 
of the components a(k) or b(k), will be zero. Specifically, if the waveform has mirror 
symmetry about t = 0, that is x(t) = x(−t), than multiplications by a sine functions will be zero 
irrespective of the frequency, and this will cause all b(k) terms to be zeros. Such mirror 
symmetry functions are termed even functions. Similarly, if the function has anti-symmetry, 
x(t) = −x(t), a so-called odd function, then all multiplications with cosines of any frequency 
will be zero, causing all a(k) coefficients to be zero. 
 
Function type Symmetry Coefficient values 
Even x(t) = x(-t) b(k) = 0 
Odd x(t) = -x(t) a(k) = 0 
 
3.4.1 Discrete-Time Fourier Analysis 
The discrete-time Fourier series analysis is an extension of the continuous analysis 
procedure described above, but modified by two operations: sampling and windowing. The 
sampling process makes the spectra repetitive at frequencies m/T. Hence the discrete 
Fourier series of any waveform is theoretically infinite, but since it is periodic and symmetric 
about fs/2, all of the information is contained in the frequency range of 0 to fs/2 ( fs /2 is the 
Nyquist frequency). This follows from the sampling theorem and the fact that the original 
analog waveform must be bandlimited so that its highest frequency fmax is less than fs/2 if 
the digitized data is to be an accurate representation of the analog waveform. 
 
The equations for computing Fourier series analysis of digitized data are the same as for 
continuous data except the integration is replaced by summation. Usually these equations 
are presented using complex variables notation so that both the sine and cosine terms can 
be represented by a single exponential term using Euler’s identity: 
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where N is the total number of points and m indicates the family member, i.e. the harmonic 
number. This number must now be allowed to be both positive and negative when used in 
complex notation: m = −(N/2), . . . , (N/2)-1.  
The inverse Fourier transform can be calculated as: 
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Applying the rectangular-to-polar transformation is also apparent that |X(m)| gives the 
magnitude for the sinusoidal representation of the Fourier series while the angle of X(m) 
gives the phase angle for this representation, since X(m) can also be written as: 
 
~   ∑ # pyv 0#j   4∑ # vno0#j jP#ajP#a                                                   (3.24) 
 
As mentioned above, for computational reasons, X(m) must be allowed to have both positive 
and negative values for m; negative values imply negative frequencies, but these are only a 
computational necessity and have no physical meaning.  
 
The discrete Fourier transform produces a function of m. To convert this to frequency note 
that: 
 
      

jO  
O
j                                                                                                      (3.25) 
 
where  is the fundamental frequency, O is the sample interval, O is the sample 
frequency, N is the number of points in the waveform and   jO is the period of the 
waveform. Substituting   O the equation for the discrete Fourier transform can also 
be written as:  
 
~   ∑ #IP40#OjP#a                                                                                                  (3.26) 
 
which may be more useful in manual calculations. 
 
If the waveform of interest is truly periodic, then the approach described above produces an 
accurate spectrum of the waveform. In this case, such analysis should properly be termed 
Fourier series analysis, but is usually termed Fourier transform analysis. This latter term 
more appropriately applies to aperiodic or truncated waveforms. The algorithms used in all 
cases are the same, so the term Fourier transform is commonly applied to all spectral 
analyses based on decomposing a waveform into sinusoids. 
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From the discrete Fourier series equation above, the number of points produced by the 
operation is N, the number of points in the data set. However, since the spectrum produced 
is symmetrical about the midpoint, N/2 (or fs/2 in frequency), only half the points contain 
unique information. If the sampling time is Ts, then each point in the spectra represents a 
frequency increment of 1/(NTs). As a rough approximation, the frequency resolution of the 
spectra will be the same as the frequency spacing 1/(NTs) [Boudreaux et al., 1995]. 
Increasing the sample interval Ts, should improve the frequency resolution but since that 
means a decrease in fs, the maximum frequency in the spectra, fs/2 is reduced limiting the 
spectral range. One simple way of increasing N even after the waveform has been sampled is 
to use zero padding. Zero padding is legitimate because the undigitized portion of the 
waveform is always assumed to be zero. Under this assumption, zero padding simply adds 
more of the unsampled waveform. The zero-padded waveform appears to have improved 
resolution because the frequency interval is smaller. In fact, zero padding does not enhance 
the underlying resolution of the transform since the number of points that actually provide 
information remains the same. However, zero padding does provide an interpolated 
transform with a smoother appearance.  
 
3.4.2 Power Spectrum 
The power spectrum is commonly defined as the Fourier transform of the autocorrelation 
function. In continuous and discrete notation, the power spectrum equation becomes: 
 
R   SIP0F                                                                                                      (3.27) 
 
R  ∑ S#IP0#OjP#a                                                                                                  (3.28) 
 
 
Figure 3.4: Power Spectrum of a waveform composed of two sines (100Hz and 200Hz) 
sampled at 1Ksps. 
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3.4.3 Short-Term Fourier Transform: The 
Spectrogram 
Classical spectral analysis techniques represent powerful signal processing tools if one is not 
especially concerned with signal timing. They provide a complete and appropriate solution 
for waveforms that are stationary (e.g. waveforms that do not change their properties over 
the length of the analysis). Waveforms of biological origin are not stationary, and change 
substantially in their properties over time. Moreover, it is these changes with time that are 
often of primary interest. Fourier analysis provides a good description of the frequencies in a 
waveform, but not their timing. However, timing is encoded in the phase portion of the 
transform, and this encoding is difficult to interpret and recover.  
 
A time–frequency method is usually based on the slicing of the waveform of interest into a 
number of short segments and performing the analysis on each of these segments, usually 
using the standard Fourier transform. A window function is applied to a segment of data, 
effectively isolating that segment from the overall waveform, and the Fourier transform is 
applied to that segment. This is termed the spectrogram or Short-Term Fourier Transform 
since the Fourier Transform is applied to a segment of data that is shorter, often much 
shorter, than the overall waveform.  
The basic equation for the spectrogram in the continuous domain is: 
 
~],    ]  IP4F QP                                                                                       (3.29) 
 
where w(t-τ) is the window function and τ is the variable that slides the window across the 
waveform x(t). 
The discrete version of the spectrogram is: 
 
~, ^  ∑ #"# 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IP4#j $j#a                                                                                    (3.30) 
 
    
Figure 3.5: Spectrogram of a 15Hz sine before t = 1 sec and 50Hz after t = 1 sec. 
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There are two main problems with the spectrogram:  
• selecting an optimal window length for data segments that contain several different 
features may not be possible; 
• the time–frequency tradeoff: shortening the data length N, to improve time 
resolution will reduce frequency resolution which is approximately 1/(NTs).  
Shortening the data segment could also result in the loss of low frequencies that are no 
longer fully included in the data segment. Hence, if the window is made smaller to improve 
the time resolution, then the frequency resolution is degraded and vice versa. This time–
frequency tradeoff has been equated to an uncertainty principle where the product of 
frequency resolution B and time T must be greater than some minimum: 
 
 =  >                                                                                                                                          (3.31) 
 
Despite these limitations, the spectrogram has been used successfully in a wide variety of 
problems, particularly those where only high frequency components are of interest and 
frequency resolution is not critical.  
 
3.5 Digital Filters 
A filter can be viewed as a linear process in which the input signal’s spectrum is reshaped in 
some well-defined manner. Filters differ in the way they achieve this spectral reshaping, and 
can be classified into two groups based on their approach. These two groups are termed 
finite impulse response (FIR) filters and infinite impulse response (IIR) filters. 
 
3.5.1 The Z-Transform 
The frequency-based analysis is the most useful tool for analyzing systems or responses in 
which the waveforms are periodic or aperiodic, but cannot be applied to transient responses 
of infinite length, such as step functions, or systems with nonzero initial conditions. These 
shortcomings motivated the development of the Laplace transform in the analog domain. 
Laplace analysis uses the complex variable O (O  k  4) as a representation of complex 
frequency in place of 4 in the Fourier transform.  
 
The Z-transform is a digital operation analogous to the Laplace transform in the analog 
domain, and it is used in a similar manner. The Z-transform is based around the complex 
variable , where  is an arbitrary complex number, ||I4. This variable is also termed the 
complex frequency, and as with its time domain counterpart, the Laplace variable O, it is 
possible to substitute I4 for  to perform a strictly sinusoidal analysis. 
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The Z-transform follows the format of the general transform equation and is also similar to 
the Fourier transform equation: 
 
~  ∑ ##aP P#                                                                                                               (3.32) 
 
where  is an arbitrary complex variable. The probing function for this transform is simply 
P#. In any real application, the limit of the summation will be finite, usually the length of 
#. When identified with a data sequence, P# represents an interval shift of n samples, 
or an associated time shift of #O seconds. This time shifting property of P# can be formally 
stated as: 
 
#  ^  P^#                                                                                                        (3.33) 
 
For example, the time shifting characteristic of the Z-transform can be used to define a unit 
delay process P. For such a process, the output is the same as the input, but shifted (or 
delayed) by one data sample (Fig. 3.6). 
 
 
 
Figure 3.6: A unit delay process. 
 
3.5.1.1 Digital Transfer Function 
As in Laplace transform analysis, one of the most useful applications of the Z-transform lies 
in its ability to define the digital equivalent of a transfer function. By analogy to linear 
system analysis, the digital transfer function is defined as: 
 
   ~                                                                                                                                     (3.34) 
 
Most transfer functions can be complicated, including polynomials of  in both the 
numerator and denominator, just as analog transfer functions contain polynomials of O: 
 
   NQNQN00QQNjjQEQE0QQE		                                                                                                  (3.35) 
 
While H(z) has a structure similar to the Laplace domain transfer function H(s), there is no 
simple relationship between them. For example, unlike analog systems, the order of the 
numerator N, need not be less than, or equal to, the order of the denominator D, for 
stability. In fact, systems that have a denominator order of 1 are more stable that those 
having higher order denominators.  
 
x(n-1) x(n) P 
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From the digital transfer function H(z), it is possible to determine the output given any input. 
In the Z-transform domain this relationship is simply: 
 
   ~  ~ ∑ N^j^ #∑ EG	G #                                                                                        (3.36) 
 
The input/output or difference equation analogous to the time domain equation can be 
obtained by applying the time shift interpretation to the term P#: 
 
.#   ∑ N^#  ^^a  ∑ EG.#  GGa                                                                   (3.37) 
 
All basic digital filters can be interpreted as linear digital processes, and, in fact, the term 
digital filter is often used interchangeably with digital systems. Filter design, then, is simply 
the determination of the appropriate filter coefficients, a(n) and b(n), that provide the 
desired spectral shaping. If the frequency spectrum of H(z) is desired, it can be obtained 
substituting   I4: 
 
    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∑ N#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                                                                              (3.38) 
 
where fft indicates the Fourier transform. 
  
3.5.2 Finite Impulse Response Filters 
Finite Impulse Response (FIR) filters have transfer functions that have only numerator 
coefficients, i.e. H(z) = B(z). This leads to an impulse response that is finite, hence the name. 
They have the advantage of always being stable and having linear phase shifts. In addition, 
they have initial transients that are of finite durations. The downside of FIR filters is that they 
are less efficient in terms of computer time and memory than IIR filters. FIR filters are also 
referred to as non-recursive because only the input (not the output) is used in the filter 
algorithm. FIR filters are also referred to as a moving average process. This term is used for 
any process that uses a moving set of multiplier weights, even if the operation does not 
really produce an average. 
The general equation for an FIR filter is a simplification of Eq. (3.37) that becomes: 
 
.^   ∑ N#^  ##a                                                                                                         (3.39) 
 
where b(n) is the coefficient function (also referred to as the weighting function) of length L, 
x(n) is the input, and y(n) is the output. This is identical to the convolution equation with the 
impulse response h(n) replaced by the filter coefficients b(n). Eq. (3.39) indicates that the 
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filter coefficients (or weights) of an FIR filter are the same as the impulse response of the 
filter. Since the frequency response of a process having an impulse response h(n) is simply 
the Fourier transform of h(n), the frequency response of an FIR filter having coefficients b(n) 
is just the Fourier transform of b(n): 
 
~   ∑ N#I40#jjP#a                                                                                                           (3.40) 
 
The inverse operation, going from a desired frequency response to the coefficient function 
b(n), is known as filter design. Since the frequency response is the Fourier transform of the 
filter coefficients, the coefficients can be found from the inverse Fourier transform of the 
desired frequency response. 
 
3.5.3 Infinite Impulse Response Filters 
The primary advantage of Infinite Impulse Response (IIR) filters over FIR filters is that they 
can usually meet a specific frequency criterion, such as a cutoff sharpness or slope, with a 
much lower filter order (i.e., a lower number of filter coefficients). The transfer function of 
IIR filters includes both numerator and denominator terms unlike FIR filters which have only 
a numerator. The major disadvantage of IIR filters is that they have nonlinear phase 
characteristics. Since IIR filters have transfer functions that are the same as a general linear 
process having both poles and zeros, many of the concepts of analog filter design can be 
used with these filters. One of the most basic of these is the relationship between the 
number of poles and the slope, or rolloff of the filter beyond the cutoff frequency. The 
asymptotic downward slope of a filter increases by 20 db/decade for each filter pole, or filter 
order. Determining the number of poles required in an IIR filter given the desired 
attenuation characteristic is a straightforward process. 
Another similarity between analog and IIR digital filters is that all of the well-known analog 
filter types can be duplicated as IIR filters. Specifically the Butterworth, Chebyshev Type I 
and II, and elliptic designs can be implemented as IIR digital filters. Butterworth filters 
provide a frequency response that is maximally flat in the pass-band and monotonic overall. 
To achieve this characteristic, Butterworth filters sacrifice rolloff steepness; hence, the 
Butterworth filter will have a less sharp initial attenuation characteristic than other filters. 
The Chebyshev Type I filters feature faster rolloff than Butterworth filters, but have ripple in 
the pass-band. Chebyshev Type II filters have ripple only in the stop-band and a monotonic 
pass-band, but they do not rolloff as sharply as Type I. The ripple produced by Chebyshev 
filters is termed equiripple since it is of constant amplitude across all frequencies. Finally, 
elliptic filters have steeper rolloff than any of the above, but have equiripple in both the 
pass-band and stop-band. In general, elliptic filters meet a given performance specification 
with the lowest required filter order (Fig. 3.7). 
 
66 
 
 
Figure 3.7: Butterwort, Chebyshev and Elliptic frequency response. 
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Chapter 4 
 
Wearable Devices and Systems for 
Cardiovascular Monitoring 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wearable devices allow clinicians, physiologists, professional and people themselves to have 
access to more and more information from the human body trough miniature sensors placed 
in some places of interest.  
 
This chapter give an overview of wearable device used for biomedical signals monitoring and 
show the wearable device developed and realized for monitoring of certain cardiovascular 
disease, such as sleep apnoea, continuous blood pressure measurement and wavelet 
analysis of PPG signals measured in patients with heart attack, deep vein thrombosis anf 
atrial fibrillation. 
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4.1 Overview of Wearable Devices 
Wearable systems are taking more and more importance in our life. They present to us in 
numerous forms, from standalone devices like smart phones, MP3 players, Personal Data 
Assistant (PDA), mobile phones to more advanced systems offering sensing and interaction 
with the user or remote professional. Wearable sensing of human physiological signal is for 
instance performed to address health application needs as well as wellness, sports activities 
and clinicians objectives. These systems allow clinicians, physiologists, professional and 
people themselves to have access to more and more information from the human body and 
the environment. They typically rely on wireless, miniature sensors enclosed in patches or 
bandages, or in items that can be worn, such as a ring or a shirt. They take advantage of 
hand-held units to temporarily store physiological data and then periodically upload that 
data to a database server via a wireless LAN or a cradle that allow Internet connection. The 
data sets recorded using these systems are then processed to detect events predictive of 
possible worsening of the patient’ s clinical situation or they are explored to assess the 
impact of clinical interventions. 
 
4.1.1 Wearable Sensing of Physiological 
Parameters 
The early prototypes of wearable medical systems are mainly based on body-worn devices, 
which are designed to be miniaturized, integrated, networked, digitalized, and smart for e-
Health application [Poon et al., 2008]. Body-worn medical systems can typically gather data 
from sensors located only in a specific and usually relatively small body area and cannot 
fulfill, alone, all the needs for sensing, actuating, displaying, and interacting with the user. An 
alternative approach to achieve wearable monitoring is to integrate sensors in clothing 
items. Intelligent biomedical clothing [Lymberis et al., 2003] refers usually to clothes with 
sensors that are close to or in contact with the skin [Lymberis et al., 2007]. The sensors are 
either embedded in the fabric of the garment, or it is the fabric itself that is used as a sensor 
or a sensor suite [Marculescu et al., 2003; Carpi et al., 2005]. Several prototypes of wearable 
medical devices or systems are shown in Fig. 4.1. 
 
           
Figure 4.1: Examples of prototype of wearable medical devices/systems. 
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As an example of wearable systems, LifeShirt is a noninvasive, continuous ambulatory 
monitoring system that can collect data during a person’s daily routine [LifeShirt, 2008; 
Grossman, 2004]. However, it is unsuitable for lengthy continuous monitoring due to the 
cumbersome recorder and peripheral attachment to be carried around. To address the 
limitations of the first prototype developed, researchers shifted their focus on smart textiles. 
Smart textiles have become one of the thriving areas of application for materials and 
nanotechnology research for the purpose of health monitoring. Smartshirt, collects analog 
signals through conductive fiber sensors and transfers them through a conductive fiber grid 
knitted in the T-shirt [Sensatex, 2007]. 
 
Up-to-date, sensing body movements or physiological signals, particularly the ECG and 
respiration, remains the main target of a wearable device. The measurement of blood 
pressure, for example, is still a challenge for wearable device because of the conventional 
cuff-based principle utilized for blood pressure measurement. In a recent work [Zhang et al., 
2006; Chan et al., 2008] a Health-Shirt (h-Shirt) that can monitor bloos pressure cufflessly 
and continuously has been proposed. The h-Shirt is designed to simultaneously record ECG 
and PPG and uses them to estimate blood pressure with the Pulse Transit Time (PTT) 
method. ECG is captured from the two wrists, with a reference electrode placed on the 
forearm to avoid respiration induced noise. The electrodes were made of e-textile materials. 
A photoreflective sensor capture PPG from the fingertip. Fig. 4.2 shows the shirt when the 
user is measuring blood pressure and ECG continuously. 
 
 
Figure 4.2: The h-shirt prototype. 
 
Other studies performed in the area of wearable devices include:  
• a wearable physiological monitoring system for space and terrestrial applications 
named Life Guard [Mundt et al., 2005]; 
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• the Armband SenseWear wearable body monitor that has been used to study body 
movement and energy expenditure in healthy as well as subjects with chronic 
obstructive pulmonary disease [Pitta et al., 2006]; 
• the WEALTHY system that is made up of a sensorized cotton shirt that integrates 
carbon-loaded elastometer strain sensors and fabric bio-electrodes, enabling the 
monitoring of respiration, ECG, electromyogram, body posture and movement 
[WEALTHY, 2002]; 
• a textile based wearable system, MagIC, designed for unobtrusively recording 
cardiorespiratory and motion signals during daily life and in a clinical environment on 
patients with different cardiovascular conditions [Rienzo et al., 2005]; 
• the MyHeart wearable monitoring system that focuses on integration of unobtrusive 
sensors into everyday garments and miniaturized on-body electronic modules for 
data processing and storage with dedicated software for data analysis like ECG 
preprocessing and motion artifact detection, computation of heart rate and HRV 
[Pacelli et al.,2006; Lauter, 2004]; 
• ... 
 
4.2 The Developed Wearable Device 
The developed wearable device is depicted in Fig. 4.3. 
 
 
Figure 4.3: The developed wearable device: block diagram (left), PCB top view (center) and 
PCB bottom view (right). 
 
Battery powered for patient’s safety, the device can drive both the red and infrared emitters 
of a standard SpO2 sensor (Fig. 4.4). 
 
71 
 
           
Figure 4.4: Standard SpO2 sensors: wrapper (left), fingertip (center) and ear lobe (right). 
 
The analog signal conditioning block is composed of a single-supply two-stage inverting 
amplifier with variable gain able to converts the photocurrent coming from the SpO2 sensor 
in a voltage with a dynamic range appropriate for the A/D converter input (Fig. 4.5).  
 
 
 
Figure 4.5: Bode diagram of the analog part of the wearable device developed. 
 
The digital block is composed of a high performance and low power 16-bit digital signal 
controller (i.e. Microchip dsPIC33FJ12MC202). It controls all the blocks of the device, filters 
the PPG signal in order to remove motion and environmental artifacts, and continuously 
analyzes the digitalized version of the PPG signals in order to execute application algorithm 
and needs. 
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Through a radio frequency link in the ISM band based on a IEEE 802.15.4 transceiver at 
2.4GHz (i.e. Microchip MRF24J40), the wearable device can communicates with an internet 
gateway or with a wireless USB dongle for remote and continuous data analysis, clinical 
monitoring and alarm catch. 
 
The picture of the realized internet gateway with its block diagram are shown in Fig. 4.6 and 
Fig. 4.7 respectively.  
 
 
Figure 4.6: The developed internet gateway. 
 
 
Figure 4.7: Block diagram of the developed internet gateway. 
 
The internet gateway is mainly composed of a Microchip transceiver at 2.4GHz connected to 
an IEEE 802.3 10baseT Ethernet controller embedded in a low power microcontroller (i.e. 
Microchip PIC18F67J60). 
 
The picture of the realized wireless USB dongle with its block diagram are shown in Fig. 4.8 
and Fig. 4.9 respectively.  
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Figure 4.8: The developed wireless USB dongle. 
 
 
Figure 4.9: Block diagram of the developed wireless USB dongle. 
 
The wireless USB gateway is mainly composed of a Microchip transceiver at 2.4GHz 
connected to a USB controller embedded in a low power microcontroller (i.e. Microchip 
PIC18F4550). 
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Chapter 5 
 
Continuous Detection and Screening of 
Sleep Apnea Disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As depicted in section 2.2.2, sleep apnoea is a common sleep disorder characterized by brief 
interruptions of breathing during sleep, which causes the major part of unknown death in 
healthy subjects. The 90 percent of patient with sleep apnoea don’t know to have this 
disease, because of the small number of symptoms and because the gold standard in 
diagnosing of SA is overnight polysomnography. 
 
This chapter show the biomedical system and application in which the wearable device 
developed is used for the continuous detection and screening of sleep apnoea disease at 
home thanks to a real-time algorithm based on the heart rate variability analysis. 
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5.1 Heart Rate Variability Analysis 
Heart Rate Variability (HRV) analysis is the standard to describe variations of instantaneous 
heart rate and RR intervals. It is mainly used for the non-invasive evaluation of the synergetic 
action of the two branches of the Autonomous Nervous System to maintain cardiovascular 
parameters in their optimal ranges [Levy et al., 1994]. In response of physical exercise, 
thoughts and emotions, the parasympathetic system slow HR, while sympathetic system 
accelerate it. 
 
The clinical importance of HRV became appreciated in the late 1980s, when it was confirmed 
that HRV was a strong and independent predictor of mortality after an acute myocardial 
infarction [Kleiger et al., 1987; Malik et al., 1989; Bigger et al., 1992]. With the availability of 
new, digital, high-frequency, 24-hour multichannel ECG recorders, HRV has the potential to 
provide additional valuable insight into physiological and pathological conditions and to 
enhance risk stratification.  
 
There are two main methods to perform an HRV analysis: one in the time domain and one in 
the frequency domain.  
 
In the time domain method, starting from short-term 5-minute recordings and nominal 24-
hour long-term ECG recordings, the normal-to-normal (NN) intervals (all intervals between 
adjacent QRS complexes) are determined (the so calld tachogram) (Fig. 5.1).  
 
 
Figure 5.1: Interval tachogram of 256 consecutive RR values in a normal subject at supine 
rest. 
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Simple time domain
 
variables that can be calculated include the mean NN interval,
 
the mean 
heart rate, the difference between the longest and shortest
 
NN interval, the difference 
between night and day heart rate, and
 
so forth. From a series of instantaneous heart rates or 
cycle intervals, particularly
 
those recorded over longer periods,
 
more complex statistical time 
domain measures can be calculated (Table 5.1). These variables
 
may be derived from 
analysis of the total ECG recording or may
 
be calculated using smaller segments of the 
recording period.
 
The latter method allows comparison of HRV to be made during
 
varying 
activities, for example, rest, sleep, and so on. 
 
Variable Units Description 
SDNN ms Standard deviation of all NN intervals. 
SDANN ms Standard deviation of the average of NN intervals in all 5-min segments 
of the entire recording. 
RMSSD ms The square root of the mean of the sum of the squares of differences 
between adjacent NN intervals. 
SDNN 
index 
ms Mean of the standard deviations of all NN intervals for all 5-min 
segments of the entire recording. 
SDSD ms Standard deviation of differences between adjacent NN intervals. 
NN50 
count 
 Number of pairs of adjacent NN intervals differing by more than 50 ms 
in the entire recording. 
pNN50 % NN50 count divided by the total number of NN intervals. 
Table 5.1: Time domain measures of HRV analysis. 
 
The simplest variable to calculate is the standard deviation
 
of the NN intervals (SDNN), that 
is, the square root of variance.
 
Since variance is mathematically equal to total power of 
spectral analysis,
 
SDNN reflects all the cyclic components responsible for variability
 
in the 
period of recording. In many studies SDNN is calculated
 
over a 24-hour period and thus 
encompasses short-term hear rate variations
 
as well as the lowest-frequency components 
seen in a 24-hour
 
period. As the period of monitoring decreases, SDNN estimates
 
shorter and 
shorter cycle lengths. It also should be noted that
 
the total variance of HRV increases with 
the length of analyzed
 
recording [Saul et al., 1988]. Thus, on arbitrarily selected ECGs, SDNN 
is not
 
a well-defined statistical quantity because of its dependence
 
on the length of recording 
period. In practice, it is inappropriate
 
to compare SDNN measures obtained from recordings 
of different
 
durations. On the contrary, durations of the recordings used
 
to determine SDNN 
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values should be standardized. Short-term 5-minute recordings appear to be appropriate 
options. 
 
Other commonly used statistical variables calculated from segments of
 
the total monitoring 
period include SDANN, the standard deviation
 
of the average NN intervals calculated over 
short periods, usually
 
5 minutes, which is an estimate of the changes in heart rate
 
due to 
cycles longer than 5 minutes, and the SDNN index, the
 
mean of the 5-minute standard 
deviations of NN intervals calculated
 
over 24 hours, which measures the variability due to 
cycles
 
shorter than 5 minutes. The most commonly used measures derived from interval 
differences include
 
RMSSD, the square root of the mean squared differences of successive
 
NN intervals, NN50, the number of interval differences of successive
 
NN intervals greater 
than 50 ms, and pNN50, the proportion derived
 
by dividing NN50 by the total number of NN 
intervals. All of these
 
measurements of short-term variation estimate high-frequency
 
variations in heart rate and thus are highly correlated.
  
 
In the frequency domain, the Power Spectral Density (PSD) analysis of the tachogram 
provides the basic information of how power distributes as a function of frequency.  
 
In short-term recordings, three main spectral components are distinguished [Drinnan et al., 
2000]:  
• VLF (Very Low Frequencies); 
• LF (Low Frequencies); 
• HF (High Frequencies). 
 
The variety of frequency domain measures of HRV analysis for short-term recordings are 
depicted in Table 5.2. The measurement of VLF, LF, and HF power components is usually 
made in absolute values of power but LF and HF may also be normalized relatively to the 
total power minus the VLF component. 
 
Variable Units Description Freq. range 
Total 
power 
ms² The variance of NN intervals over the temporal 
segment. 
<0.4Hz 
VLF ms² Power in VLF range. <0.04 Hz 
LF ms² Power in LF range. 0.04-0.15 Hz 
LF norm ms² LF power in normalized units. 
LF/(total power-VLF)*100 
0.04-0.15 Hz 
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HF ms² Power in HF range 0.15-0.4 Hz 
HF norm ms² HF power in normalized units. 
HF/(total power-VLF)*100 
0.15-0.4 Hz 
LF/HF  LF/HF Ratio  
Table 5.2: Frequency domain measures of HRV analysis in a short-term recording. 
 
The distribution
 
of the power and the central frequency of LF and HF are not
 
fixed but may 
vary in relation to changes in autonomic modulations of
 
heart period [Pagani et al., 1986; 
Furlan et al., 1990; Berger et al., 1986]. The representation
 
of LF and HF in normalized units 
emphasizes the controlled and
 
balanced behavior of the two branches of the autonomic 
nervous
 
system. Moreover, the normalization tends to minimize the effect
 
of the changes in 
total power on the values of LF and HF components. Nevertheless, normalized units should 
always be quoted
 
with absolute values of the LF and HF power in order to describe
 
completely the distribution of power in spectral components.
  
 
Spectral analysis also may be used to
 
analyze the sequence of NN intervals of the entire 24-
hour period.
 
The result then includes a ULF component, in addition to VLF,
 
LF, and HF 
components. Because of the important differences in the interpretation of
 
the results, the 
spectral analyses of short-term and long-term
 
ECGs should always be strictly distinguished. 
 
Methods for the calculation of PSD may be generally classified as nonparametric and 
parametric. In most instances, both methods provide comparable results (Fig. 5.2). The 
advantages of the nonparametric methods are the simplicity of the algorithm used (FFT) and 
the high processing speed, while the advantages of parametric methods are the smoother 
spectral components that can be distinguished independent of preselected frequency bands 
and easy post-processing of the spectrum with an automatic calculation of low and high-
frequency power components. 
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Figure 5.2: HRV spectra calculated by a FFT non-parametric algorithm (left plot) and by a 
parametric algorithm (right plot). 
 
Increased HF power represent too quicker changes in heart rate due to excessive 
sympathetic activity while increased LF power represent slower changes in heart rate due to 
parasympathetic activity. 
 
5.2 Detection of SA from frequency analysis 
of HRV 
Previous scientific researches have demonstrated that HRV analysis in the time and 
frequency domain [Drinnan et al., 2000] can give reasonably high detection accuracy of the 
sleep apnoea occurrence for manual and automatic screening. These results also show that 
HRV spectrum analysis give the most informative feature than the statistical method of the 
time domain method [Xu et al., 2008].  
 
Patients with sleep apnoea tend to have a spectral peak lying between 0.01 and 0.05 Hz, 
with the width of the peak indicating variability in the recurrence rate of the apnoea 
[Drinnan et al., 2000]. In this way, by a fixed threshold of 3,15 used to discriminate the ratio 
of the content of two spectral regions obtained by dividing the area under the spectral curve 
between 0.01 and 0.05 Hz by the area between 0.005 and 0.01 Hz, an automated 
classification of SA events can give an overall classification score of 90%. The block diagram 
of the algorithm of this automatic classification procedure is depicted in Fig. 5.3. 
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Figure 5.3: Automatic analysis and classification of SA events by the frequency analysis of 
HRV [Drinnan et al., 2000]. 
 
5.3 The Proposed System 
The aim of this work is to develop a wearable biomedical system capable of performing real-
time short-term HRV analysis for the continuous and real-time monitoring of the sleep 
apnoea disease at home.  
 
The proposed system is composed of two main parts hosted respectively in the Remote 
Monitoring Station (RMS) and at the patient’s home (Fig. 5.4). 
 
 
Figure 5.4: System overview for the continuous detection and screening of SA disease . 
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On the patient’s side, there are only the internet gateway for the patient’s data transmission 
to the RMS and the wearable device embedded in a comfortable glove in order to allow the 
continuous detection and screening during daily life (Fig. 5.5). 
 
 
Figure 5.5: The glove embedding the wearable device. 
 
The wearable device performs in real-time the short-term (5-min) HRV analysis from NN 
intervals measured in the PPG signal coming from a standard SpO2 wrapped sensor placed in 
one of the fingers. Fig. 5.6 shows that the detection of NN intervals from the PPG signal is 
equivalent to the traditional method based on a QRS detection algorithm from an ECG 
channel. Moreover,  the use of a standard SpO2 wrapped sensor placed in one of the fingers 
instead of the use of electrocardiogram electrodes makes the realized device patient safe, 
inexpensive and easy to use. 
 
 
Figure 5.6: NN intervals detection from lead-II ECG (A) and PPG (B). 
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Applying a fixed threshold at the frequency analysis of the heart rate variability [Drinnan et 
al., 2000], the device can continuously detect how many sleep apnoea events has been 
occurred in the previous 5-min and can activate an alarm if the number of sleep apnoea 
events per hour cross a guard level.  
 
Through the radio frequency link in the ISM band, the smart glove communicates with the 
internet gateway connected with a remote monitoring station for the continuous data 
analysis, clinical monitoring and alarm catch. 
 
On the RMS side there is only a simple PC with a TCP/IP server and a Graphic User Interface 
(GUI) (Fig. 5.7). The server receives the data stream of the patients connected and the GUI 
performs the real-time HRV analysis in both frequency and time domain in order to provide 
to a physician the best framework for the automatic and manual detection of sleep apnoea 
occurrence. 
 
 
Figure 5.7: The Graphic User Interface at the Remote Monitoring Station. 
 
In this GUI, there are: 
• a listview that lists the name and the battery level of the wearable device of all 
patients connected with the RMS; 
• a little text area that shows selected patient info, such as patient’s address, cell 
number and medicine usually taken; 
• a plot area (PPG) that plots the real time PPG signal acquired; 
• a plot area (Tachogram) that plot the short term tachogram; 
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• a plot area (PSD) that plots the power spectrum density of the short term tachogram 
acquired for the selected patient; 
• a info area with some time and frequency domain index for the last PSD for the 
selected patient. 
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Chapter 6 
 
Continuous Cuff-less Assessment of 
Blood Pressure  from PPG signals 
 
 
 
 
 
 
 
 
The importance of accurate blood pressure measurement in the diagnosis of arterial 
hypertension, and in the precise titration of antihypertensive treatment, is largely 
acknowledged in clinical practice. The relevance of this issue has recently been further 
emphasized by hypertension management guidelines [ESH, 2003].  
 
Standard Non-Invasive Blood Pressure (NIBP) monitoring in a clinical or research setting is 
often performed using techniques that evolved in the 19th century. However, traditional 
sphygmomanometry is unable to monitor the short-term dynamic variability that occurs 
with BP and cannot be used for continuous monitoring of BP.  
 
A noninvasive beat to beat measurement of BP would be extremely valuable. A number of 
approaches have been developed, including most notably finger blood-volume clamping 
[Penaz, 1969] and arterial tonometry. Although some studies have suggested that there is 
usually reasonable accuracy with these systems, the technology itself is generally expensive, 
cumbersome, and prone to movement artifact.  
 
An alternative technique involves measuring the transit time of the pulse pressure wave 
through the arterial tree, but this is an unreliable marker of beat-to-beat blood pressure 
[Payne et al., 2006]. 
 
This chapter give an overview of traditional an innovative method for non-invasive blood 
pressure measurement, and illustrate the calibration of the under research cuff-less method 
of the assessment of BP from PPG signals into the wearable device developed in this thesis. 
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6.1 Arterial Blood Pressure 
The maximum pressure is called the systolic pressure while the minimum pressure is called 
the diastolic pressure. The integral of the pressure over one cardiac cycle is called the mean 
pressure, or mean arterial pressure (MAP). The difference between the systolic and diastolic 
pressure is known as the pulse pressure. Blood pressure measurements are usually acquired 
from the arterial system and may be measured invasively and non-invasively.  
 
6.2 Classical NIBP Measurements 
6.2.1 Auscultation 
Auscultation is the blood pressure reference method for non-invasive blood pressure 
measurements [AAMI, 1992]. It requires a sphygmomanometer and a stethoscope (Fig. 6.1). 
 
 
Figure 6.1: Using sphygmomanometer and stethoscope in auscultation method. 
 
A sphygmomanometer consists of an inflatable bladder with a cuff, rubber bulb for cuff 
inflation and a manometer for pressure reading.  
 
Using this method, a clinician inflates the external cuff surrounding the tissue over the 
brachial artery until the inflated pressure is above systole. The clinician then slowly releases 
the pressure while listening for heart sounds below the level of the cuff. When the systolic 
peaks are higher than the cuff pressure, audible sounds called Korotkoff sounds are 
86 
 
generated by the flow of blood and vibrations of the vessel under the cuff. The pressure 
reading at the first detection of the Korotkoff sounds indicates systolic pressure. As the cuff 
pressure is further decreased, the Korotkoff sounds become muffled and disappear. The 
pressure reading during the transition from muffling to silence is the diastolic pressure 
[Geddes, 1970]. 
 
Figure 6.2: Cuff pressure trend in auscultatory method. 
 
6.2.2 Oscillometry 
The most widely used automatic indirect blood pressure method is oscillometry [Ramsey, 
1979]. With this method, an external cuff is inflated above the systolic pressure over the 
brachial artery. The external pressure is then slowly decreased, while measuring the 
amplitude of pressure oscillations that are created by expansion of the arterial wall during 
each beat as blood is forced through the artery. The systolic pressure is determined when 
the cuff pressure significantly increases in amplitude. The mean pressure is determined 
when the cuff pressure reaches the maximum amplitude. Because there is no clear transition 
in amplitude during diastole pressure, proprietary algorithms are used to measure diastolic 
pressure (Fig. 6.3). However, usually the diastolic pressure is determined by the last major 
oscillation. Although the mechanism behind this phenomenon of pressure amplitudes is 
unknown, the MAP measurement is very robust. However, measurement of systolic pressure 
is less robust, and measurement od diastolic pressure may be questionable, depending on 
the proprietary algorithms utilized. 
 
 
Figure 6.3: Cuff pressure trend in oscillometric method. 
 Cuff size relative to arm cincumference affects the accuracy of noninvasive measurements 
[Van Montfrans et al., 1987]. 
precision depend on the expertise of the operator and do not allow a conti
measurement.  
 
6.3 Innovative 
6.3.1 Finapres 
In 1969, Jan Penaz of the University J.E. Purkyne in Czechoslovakia patented a continuous 
non-invasive blood pressure method that is commonly referred to as the volume clamp 
method or method of Penaz 
Karel Wesseling [Cejnar at al., 1988; Yamakoshi et al., 1983]
implementation is the basis of the Finapres (FINger Artery PRESsure) monitor manufactured 
by Ohmeda [Molhoek et al., 1984; Wesseling et al., 1990]
light from a light emitting diode is passed through a finger and detected. Simultaneously, a 
cuff is securely placed over the same finger with the cuff pressure continuously adju
maintain a constant transmural pressure across the digital arteries (
 
Figure 6.4: Finapres schema. 
 
During self calibration, the cuff pressure at which the pulsation amplitudes and therefore the 
finger blood volume are maximized is ass
which the artery is in a relaxed state and the arterial diameter is maximal.  After calibration, 
the monitor servo system attempts to control the pressure to this set point. At the set point, 
it is assumed that the transmural pressure equals zero and an approximately linear 
relationship exists between the intraarterial pressure and detected light. The systolic, mean, 
and diastolic finger pressures detected at this set point are assumed to equal the 
intraarterial radial systolic, mean and diastolic pressures. The last version of the Finapres is 
The original Riva Rocci method is still the most reliable but its 
NIBP Measurements 
[Penaz, 1969]. This method was subsequently developed by 
 in the 1980s. Wesseling’s 
. Using photoplethysmography, 
Fig. 6.4
umed to be an indication of the pressure during 
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available in ambulatory version and in portable version. The ambulatory version is called 
Finometer instead the portable version is called the Portapres (Fig. 6.5). 
 
      
Figure 6.5: Finapres Finometer (left) and Finapres Portapres (right). 
 
The Finapres devices allow continuous blood pressure monitoring but it has a annoying cuff 
that not allow a long-term measurement and sometimes it not respect the AAMI 
specifications (±8 mmHg) [AAMI, 1992]. 
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6.4 Cuff-less NIBP Measurements 
6.4.1 Methods based on Pulse Transit Time 
Pulse transit time (PTT), defined as the time interval for a pressure pulse to travel from one 
arterial site to another [McDonald, 1974], is one of the proposed parameters for the non-
invasive beat to beat blood pressure estimation. PTT is usually measured as the time interval 
from the characteristic points of electrocardiogram and photoplethysmographic signal in the 
same heart cycle (Fig. 6.6).  
 
Figure 6.6: Definitions of PTT. 
 
Previous literature reported that the PTT is inversely related to blood pressure: 
 
"yyo qw  . , 0U$     R  N G#
0N
R0                                                                            (6.1) 
 
where L is the distance traveled by the pulse, b is a subject-dependent coefficient 
characterizing the artery properties, and  is the blood density. 
 
"vno  qw  . , 0U$    R    R                                                                                 (6.2) 
 
where L is a biometric parameter, typically related to the subject's body size, A is a 
sensitivity factor and B is a constant. 
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6.4.2 Methods based on PPG Signals 
PTT techniques require two independent channels to measure the time interval, which are 
less convenient to users in practical application. Moreover, relationships based on PTT are 
not reliable enough to make the PTT-based approach as a surrogate marker of SBP, and DBP 
and MBP cannot be predicted from PTT [Payne et al., 2006]. 
 
For these reasons, some works were made to estimate blood pressure by using 
photoplethysmographic signal. Several features (pulse amplitude, area, width, half width, 
systolic and diastolic time (DT), etc.)  extracted from PPG signals in time domain were 
claimed to correlate with BP [Awad et al., 2001; Teng et al., 2003]. Experimental findings of 
this method demonstrate the promise of the method for the real-time characterization of a 
patient’s vascular compliance curve using a standard sigmoidal model. Once parameterized, 
the curve can be utilized for the real-time measurement of arterial blood pressure using 
non-invasive photoplethysmographic sensor. 
 
It is well known that the arterial wall demonstrates a highly nonlinear relationship between 
vascular volume V and transmural pressure R] [Ando et al., 1991], which is defined as the 
difference between the internal pressure RI ,external hydrostatic pressure R.FSH ,and 
any additional externally applied pressure RI]: 
 
R]  RI  R.FSH  RI]                                                                                                        (6.3) 
 
Typically, this nonlinear relationship can be characterized by fitting a sigmoid function to 
experimentally derived pressure-volume data, 
 
RR<  
  NQIN0R]                                                                                                                     (6.4) 
 
where N and N0 are fitting parameters with units of volume and inverse pressure, 
respectively.  
 
N  nR]
                                                                                                                            (6.5) 
 
The remaining model parameter, N0, requires additional knowledge about the pressure-
volume relationship. One method for estimating this parameter is to assume that the middle 
section of the sigmoid is approximately linear, with slope N0. If valid, the value of N0 can 
then be estimated from any two points (pressures) within this linear region (Fig. 6.7). The 
main difficulty with this approach is that it appears to require knowledge of the compliance 
curve. In particular, it requires knowledge of the pressures containing the central region of 
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Figure 6.7: Arterial compliance curves based on parameters estimated from hydrostatic 
challenge. 
 
6.5 Calibration of the PPG to BP for the 
Continuous Assessment in the Developed 
Wearable Device  
The aim of this work is the development of a wearable biomedical system for the continuous 
and real-time monitoring of blood pressure through the validation of the PPG calibration 
method. Developing such as device has the advantage to be easy to wear thanks to the use 
of a standard SpO2 sensor. Such wearable device can easily embedded ,for example, in a 
comfortable glove using a fingertip sensor or in a shoe using a standard wrapped sensor 
placed in one of the foot finger. 
 
The calibration procedure was made on five healthy volunteers wearing the device 
embedded in a comfortable cotton glove with the SpO2 standard sensor wrapped in the 
index finger. In order to calibrate the PPG signal to blood pressure, the amplitude of the PPG 
signal is measured in eight different heights for each subject and the diastolic and systolic 
value are measured with the aid of a standard sphygmomanometer. 
 
Fig. 6.8 shows the resultant plots obtained plotting the amplitude of PPG signal versus the 
measured blood pressure for every height and for every volunteer. 
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Figure 6.8: Experimental calibration of the PPG signal to blood pressure in five different 
volunteers. 
 
These experimental data confirm the standard sigmoidal model defined in Eq. (6.4). Once 
parametrized through a the calibration process illustrated above, the sigmoidal curve can be 
used to compute a real-time cuffless estimation of MBP using only a non-invasive PPG 
sensor. However, this method is subjective and the calibrations curve obtained are different 
for each volunteer. 
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Hence, is necessary a normalization of the amplitude of the PPG signals in order to obtain a 
unique calibration curve for all subjects. Fig. 6.9 shows a graph obtained normalizing the 
amplitude of the PPG signals respect to the PPG signal with the less amplitude. 
 
 
Figure 6.9: Normalized PPG versus blood pressure graph. 
 
The graph obtained shows that this normalization process don’t permit to have a unique 
objective calibration curve useful for every patient. Hence this method permit to calibrate a 
sigmoidal curve that correlate the PPG amplitude of a patient but the standardization of a 
calibration protocol is needed in order to successfully utilize such as method. Moreover, the 
calibrated sigmiodal curve is more sensible to motion artifacts, so a little shift of the SpO2 
sensor strongly influence the PPG amplitude and hence the sigmoidal curve. 
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Chapter 7 
 
Continuous Monitoring of patients 
with HA, AF and DVT through Wavelet 
Transform of PPG signals 
 
 
 
 
 
 
 
 
 
 
Due to the wide variety of signals and problems encountered in medicine and biology, the 
spectrum of applications of the wavelet transform in biomedical signal processing is 
extremely large [Aldroubi et al., 1996]. The main difficulty in dealing with biomedical objects 
is the extreme variability of the signals and the necessity to operate on a case by case basis.  
 
Wavelet analysis in biomedical signal processing ranges from the analysis of the more 
traditional physiological signals such as the electrocardiogram (ECG), to the very recent 
imaging modalities including positron emission tomography (PET) and magnetic resonance 
imaging (MRI) [Wright, 2000]. It is used usually to remove noise, artefacts, or transient 
features.  
 
This chapter show how it is possible to correlate PPG signal to heart attack, deep vein 
thrombosis and atrial fibrillation through a wavelet analysis in order to implement in the 
developed wearable device a clinical aid in the treatment of these diseases by anticoagulant 
oral therapy. 
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7.1 Wavelet Analysis 
The wavelet transform can be used as another way to describe the properties of a waveform 
that changes over time, but in this case the waveform is divided not into sections of time, 
but segments of scale [Akansu et al., 1992].  
In wavelet analysis, a variety of different probing functions may be used, but the family 
always consists of enlarged or compressed versions of the basic function, as well as 
translations. This concept leads to the defining equation for the continuous wavelet 
transform (CWT): 
 
  E, N   ] |E|
]PN
E F] QP                                                                            (7.1) 
 
where b acts to translate the function across x(t) and the variable a acts to vary the time 
scale of the probing function . If a is greater than one, the wavelet function , is stretched 
along the time axis, and if it is less than one (but still positive) it contacts the function. 
Negative values of a simply flip the probing function on the time axis. While the probing 
function   could be any of a number of different functions, it always takes on an oscillatory 
form, hence the term wavelet. The * indicates the operation of complex conjugation, and 
the normalizing factor 

√  ensures that the energy is the same for all values of a. If b = 0, and 
a = 1, then the wavelet is in its natural form, which is termed the mother wavelet [Rao et al., 
1998].  
 
 
Figure 7.1: A Morlet mother wavelet (a = 1) with two dilations (a = 2 and 4) and one 
contraction (a = 0.5). 
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The wavelet coefficients W(a, b), describe the correlation between the waveform and the 
wavelet at various translations and scales: the similarity between the waveform and the 
wavelet at a given combination of scale and position a, b. In other words, the coefficients 
provide the amplitudes of a series of wavelets, over a range of scales and translations, that 
would need to be added together to reconstruct the original signal. From this perspective, 
wavelet analysis can be thought of as a search over the waveform of interest for activity that 
most clearly approximates the shape of the wavelet. This search is carried out over a range 
of wavelet sizes: the time span of the wavelet varies although its shape remains the same.  
 
If the wavelet function  is appropriately chosen, then it is possible to reconstruct the 
original waveform from the wavelet coefficients just as in the Fourier transform [Strang et 
al., 1997]. Since the CWT decomposes the waveform into coefficients of two variables, a and 
b, a double summation (or integration) is required to recover the original signal from the 
coefficients: 
 
]    QE a P  E, N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FEFN QN a P                                                                           (7.2) 
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|0||  FQP                                                                                                                           (7.3) 
 
 
Figure 7.2: CWT of a 15Hz sine before t = 1 sec and 50Hz after t = 1 sec. 
 
 
Figure 7.3: Haar, Morlet, Mexican Hat and Meyer wavelet [Misiti et al., 2008]. 
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Figure 7.4: Coiflet wavelets [Misiti et al., 2008]. 
 
 
Figure 7.5: Symlet wavelets[Misiti et al., 2008]. 
 
 
Figure 7.6: Daubechies wavelets[Misiti et al., 2008]. 
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Figure 7.7: Biorthogonal wavelets[Misiti et al., 2008]. 
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The CWT has one serious problem: it is highly redundant. The CWT provides an oversampling 
of the original waveform: many more coefficients are generated than are actually needed to 
uniquely specify the signal. This redundancy is usually not a problem in analysis applications 
but will be costly if the application calls for recovery of the original signal. For recovery, all of 
the coefficients will be required and the computational effort could be excessive. In 
applications that require bilateral transformations, we would prefer a transform that 
produces the minimum number of coefficients required to recover accurately the original 
signal.  
 
The discrete wavelet transform (DWT) achieves this requirement by restricting the variation 
in translation and scale, usually to powers of 2. When the scale is changed in powers of 2, 
the discrete wavelet transform is sometimes termed the dyadic wavelet transform. The DWT 
may still require redundancy to produce a bilateral transform unless the wavelet is carefully 
chosen such that it leads to an orthogonal family. In this case, the DWT will produce a non-
redundant, bilateral transform [Wickerhauser, 1994]. 
 
In the DWT, a new concept is introduced termed the scaling function, a function that 
facilitates computation of the DWT. To implement the DWT efficiently, the finest resolution 
is computed first. The computation then proceeds to coarser resolutions, but rather than 
start over on the original waveform, the computation uses a smoothed version of the fine 
resolution waveform. This smoothed version is obtained with the help of the scaling 
function. In fact, the scaling function is sometimes referred to as the smoothing function. 
The definition of the scaling function uses a dilation or a two-scale difference equation: 
 
]  ∑ √0T#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where c(n) is a series of scalars that defines the specific scaling function. This equation 
involves two time scales (t and 2t) and can be quite difficult to solve.  
In the DWT, the wavelet itself can be defined from the scaling function: 
 
]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                                                                                              (7.5) 
 
where d(n) is a series of scalars that are related to the waveform x(t) and that define the 
discrete wavelet in terms of the scaling function.  
 
While the DWT can be implemented using the above equations, it is usually implemented 
using filter bank techniques. The use of a group of filters to divide up a signal into various 
spectral components is termed sub-band coding. The most basic implementation of the DWT 
uses only two filters as in the filter bank shown in Fig. 7.8. 
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Figure 7.8: Simple filter bank consisting of only two filters applied to the same waveform. The 
filters have low-pass and high-pass spectral characteristic. 
 
The waveform under analysis is divided into two components, .G# and .#, by the 
digital filters  and . The spectral characteristics of the two filters must be 
carefully chosen with  having a low-pass spectral characteristic and   a high-
pass spectral characteristic. The high-pass filter is analogous to the application of the 
wavelet to the original signal, while the low-pass filter is analogous to the application of the 
scaling or smoothing function. If the filters are invertible filters, then it is possible, at least in 
theory, to construct complementary filters that will recover the original waveform from 
either of the sub-band signals, .G# (approximation) and .# (detail). The original 
signal can often be recovered even if the filters are not invertible, but both sub-band signals 
will need to be used. Signal recovery is illustrated in Fig. 7.9 where a second pair of filters, 
< and < operate on the high and low-pass sub-band signals and their sum is used 
to reconstruct a close approximation of the original signal. 
 
 
 
 
 
 
 
 
Figure 7.9: A typical wavelet application using filter bank containing only two filters. The 
input waveform is first decomposed into sub-bands using the analysis filter bank. Some 
process is applied to the filtered signals before reconstruction. Reconstruction is performed 
by the synthesis filter bank. 
 
The Filter Bank that decomposes the original signal is usually termed the analysis filters 
while the filter bank that reconstructs the signal is termed the syntheses filters. In some 
analysis applications only the sub-band signals are of interest and reconstruction is not 
needed, but in many wavelet applications, some operation is performed on the sub-band 
signals, .G# and .#, before reconstruction of the output signal. In such cases, the 
output will no longer be exactly the same as the input.  
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There is one major concern with the general approach schematized in Fig. 7.9: it requires the 
generation of twice as many points as are in the original waveform. This problem will only 
get worse if more filters are added to the filter bank. If the analysis filters are correctly 
chosen, then it is possible to reduce the length of .G# and .# by one half and still be 
able to recover the original waveform. To reduce the signal samples by one half and still 
represent the same overall time period, we need to eliminate every odd point. This 
operation is known as downsampling. The downsampled version of y(n) would then include 
only the samples with even indices [y(2), y(4), y(6), . . . ] of the filtered signal. 
 
If downsampling is used, then there must be some method for recovering the missing data 
samples (those with odd indices) in order to reconstruct the original signal. An operation 
termed upsampling accomplishes this operation by replacing the missing points with zeros.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10: A typical wavelet application using three filters where the downsampling and 
upsamplig processes are shown. 
 
Designing the filters in a wavelet filter bank can be quite challenging because the filters must 
meet a number of criteria. The most important concern is the ability to recover the original 
signal after passing through the analysis and synthesis filter banks.  
 
A way to choose an optimal mother wavelet function is the algorithm developed in [Castro 
et al., 2000]. From the wavelet family set, the optimal mother wavelet is chosen by mean of 
best reconstruction quality and minimum coefficients obtained from the 4
th
 decomposition 
depth.  
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   ||~||0||~T||0                                                                                                                                   (7.6) 
 
where  is the reconstruct value, ~ is the signal and ~T is the reconstructed signal. 
The minimum reconstruction value is fixed to be 99%, which guarantees the preservation of  
important signal components.   
 
7.2 Wavelet Analysis in Biomedical Signal 
Processing 
Due to the wide variety of signals and problems encountered in medicine and biology, the 
spectrum of applications of the wavelet transform in biomedical signal processing is 
extremely large [Aldroubi et al., 1996]. The main difficulty in dealing with biomedical objects 
is the extreme variability of the signals and the necessity to operate on a case by case basis. 
Often, one does not know a priori what is the pertinent information and at which scale it is 
located. Moreover, the information of interest in biomedical signals is often a combination 
of features that are well localized temporally or spatially and others that are more diffuse. 
This requires the use of analysis methods sufficiently versatile to handle events that can be 
at opposite extremes in terms of their time-frequency localization. 
Wavelet analysis in biomedical signal processing ranges from the analysis of the more 
traditional physiological signals such as the electrocardiogram (ECG), to the very recent 
imaging modalities including positron emission tomography (PET) and magnetic resonance 
imaging (MRI) [Wright, 2000]. It is used usually to remove noise, artefacts, or transient 
features.  
 
In ECG processing, the wavelet analysis is used for QRS detection [Li et al., 1995]. In heart 
sound analysis, the WT is a useful tool for the time-frequency analysis and characterization 
of the murmurs, which are primarily caused by blood flow turbulence and characteristic of 
cardiac disease such as aortic stenosis or valve defects [Khadra et al., 1991]. In Computer-
Assisted Tomography (CAT) and in Magnetic Resonance Imaging (MRI), the the wavelet 
analysis is used for image enhancement and for detection of microcalcifications in 
mammograms [Clarke et al., 1994; Qian et al., 1994; Strickland et al., 1994; Yoshida et al.,  
2001]. In functional image analysis such as PET and fMRI, the the wavelet analysis is utilized 
for investigating the neuronal activity of the brain in vivo [Ruttimann et al., 1993; Rio et al.,  
1994; Unser et al.,  1995]. 
 
In PPG wavelet analysis, Leonard et al. discovered a wavelet-based algorithm for 
identification of unwell children from pulse oximeter waveform [Leonard et al., 2004]. 
In the past the photoplethysmogram has traditionally been thought to be of no value except 
to determine if a pulse oximeter is picking up a good signal and thus giving an accurate 
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reading [Moyle, 1994]. However, other works have shown that other cardiorespiratory 
variables influence the waveform [Vegfors et al., 1994; Middleton et al., 2000].  
 
Photoplethysmogram signals were obtained from 20 children fulfilling the study entry 
criteria and from 12 children of a group control. All traces were analyzed using wavelet 
techniques, first to remove the effects of noise and drift, and then to determine the wavelet 
based features that permit separation of the control group from the unwell children. 
Maximal separation was achieved when the wavelet power across the 1 Hz frequency band 
was plotted against the entropy at the 7 Hz band (Fig. 7.11). The probability that the two 
samples come from populations that are identical is p = 0.00002. 
 
 
Figure 7.11: Scatter plot of wavelet power at 1 Hz against entropy at 7 Hz showing 
differentiation of well children from unwell children. 
 
7.3 Wavelet Analysis of Acquired PPG signals 
Using the wearable device depicted in section 4.3, the Photoplethysmogram signals were  
obtained from 27 patients with atrial fibrillation disease, 30 patients with deep vein 
thrombosis disease, 15 patient with heart attack and from 20 healthy subjects of a group 
control (mean age 40 years). The aim of this work was to discover a wavelet analysis able to 
discriminate between the PPGs of the control group and the PPGs of the patients with 
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disease. In order to exclude results in the wavelet analysis imputable to different therapies 
from the patients sets, all of these patients follow the same anticoagulant oral therapy. 
 
Starting from the PPG signals of the healthy subjects and in concordance with the Castro 
algorithm for choosing the optimal mother wavelet function (Eq. (7.6)), the optimal wavelet 
function used was the Sym7. 
 
 
Figure 7.12: PPG signal of a healthy subject acquired with the wearable device realized. 
 
The wavelet decomposition used is shown in Fig. 7.13. Using the filter coefficients for the 
Sym7 wavelet, all of PPG signals are decomposed in detail and approximation until the 
second level of filter banks. 
 
 
 
 
 
 
 
 
 
 
Figure 7.13: Wavelet decomposition used for the healthy and ill PPG signal analysis. 
 
In order to discriminate between healthy and ill PPG signals, three different parameters was 
used after the wavelet transform: 
 
qoqm¨©       jP∑ /  i0j/a                                                                                            (7.7) 
 
where  is the waveform being analyzed, N is the number of samples of , and i is the mean 
value of . 
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where  is the energy of , / is the energy of any other signal in the same set, and N is 
the number of signals in the set. 
 
qowmy©       ∑ G#j/a /0                                                                                                      (7.9) 
 
where  is the entropy of  and N is the number of samples of . 
 
7.3.1 Analysis of Atrial Fibrillation PPG signals 
 
Figure 7.14: PPG signal of a subject with AF disease acquired with the wearable device 
realized. 
 
In spite of the PPG signal in patients with AF disease is clearly different from a PPG signal of a 
healthy subjects, plotting the energy (Fig. 7.15) or the normalized energy (Fig. 7.16) of the 
wavelet analysis at various scale of approximation versus the entropy, don’t permit to 
discriminate PPGs of patients with AF disease from PPGs of healthy subjects. 
 
 
Figure 7.15: Energy versus entropy of the DD2 level of the wavelet analysis of healthy PPGs 
and of PPGs from subjects with AF disease. 
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Figure 7.16: Normalized energy versus entropy of the DD2 level of the wavelet analysis of 
healthy PPGs and of PPGs from subjects with AF disease. 
 
7.3.2 Analysis of Deep Vein Thrombosis PPG 
signals 
 
Figure 7.17: PPG signal of a subject with DVT disease acquired with the wearable device 
realized. 
 
The PPGs acquired from patients suffering from DVT are very similar to those acquired from 
healthy subjects. The wavelet analysis don’t permit to distinguish from healthy PPGs and ill 
PPGs, although the greater part of ill PPGs are clustered (Fig. 7.18). 
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Figure 7.18: Energy versus entropy of the AD2 level of the wavelet analysis of healthy PPGs 
and of PPGs from subjects with DVT disease. 
 
7.3.3 Analysis of Heart Attack PPG signals 
 
Figure 7.19: PPG signal of a subject with HA disease acquired with the wearable device 
realized. 
 
In spite of the PPG signals in patients with HA disease are very similar to PPG signals of 
healthy subjects, the wavelet analysis permit to clearly distinguish between healthy PPGs 
and ill PPGs, simply plotting energy versus entropy of the wavelet transform of the second 
level of approximation (AA2). 
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Figure 7.20: Energy versus entropy of the AA2 level of the wavelet analysis of healthy PPGs 
and of PPGs from subjects with HA disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
109 
 
 
Chapter 8 
 
A DVB-T based System for Tele-Home 
Care Practice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to reduce the costs for both the patients and the public administration, tele-home 
care systems are today often used for clinical practice. They permit to avoid the 
overcrowding of ambulatories for simple routine examinations and, in the case of chronic 
patients that must be frequently monitored, to avoid the costs and the waste of time of an 
ambulatory examination for simple physiological measurements that they could easily 
perform at home, sending the recorded data to the care staff in the appropriate 
department. However, these telemedicine systems are usually PC based or use complex 
hardware and software products. Even if such technologies are quite popular today, they are 
frequently used only by relatively young people, which are not the primary tele-home care 
target. Cardiopathic and diabetic patients need to be frequently monitored and in some 
cases they could easily perform at home the requested physiological measurements (i.e. 
glycemia, heart rate, blood pressure and body weight) sending the measured data to the 
care staff in the hospital.  
 
This chapter shows a low-cost tele-home care system based on the Digital Video Broadcast 
Terrestrial (DVB-T) technology for the remote monitoring of patients with diabetes and 
suffering from cardiovascular diseases, even exploitable by elderly people. 
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8.1 Introduction to Interactive TV 
8.1.1 Digital Video Broadcasting 
The Digital Video Broadcasting (DVB) Project is an Alliance of about 300 companies aimed to 
define the Digital Television standardization. There are different standards based on the 
transmission mean [DVB, 1999]:  
• DVB-S for Satellite; 
• DVB-C for Cable; 
• DVB-T for Terrestrial; 
• DVB-H for handheld devices. 
 
 
Figure 8.1: DVB standards over the world. 
 
These standards define the physical layer and data link layer of the distribution system. 
Devices interact with the physical layer via a synchronous parallel interface (SPI), 
synchronous serial interface (SSI), or asynchronous serial interface (ASI). All data is 
transmitted in MPEG-2 transport streams with some additional constraints (DVB-MPEG).  
 
These distribution systems differ mainly in the modulation schemes used and error 
correcting codes used, due to the different technical constraints. DVB-S uses QPSK, 8PSK or 
16-QAM. DVB-C uses QAM: 16-QAM, 32-QAM, 64-QAM, 128-QAM or 256-QAM. Lastly, DVB-
T uses 16-QAM, 64-QAM or QPSK in combination with COFDM and can support hierarchical 
modulation. 
 
 
 8.1.2 Digital Video Broadcasting Terrestrial
Digital Video Broadcasting Terrestrial 
broadcast transmission of 
compressed digital audio/video/data MPEG
Multiplexing and a modulation technique compati
of the analog transmission channel (i.e. QPSK, 16QAM and 64QAM). The compressed video, 
audio, and data streams of one TV channels are multiplexed together to form a Programme 
Elementary Stream (PES). The basic digita
2 Transport Stream (TS), which is formed joining together one or more PES. From the 
receiver’s point of view, all the TV channel and services are received at once but it only 
demultiplexes and then decodes
Fig. 8.2 shows the scheme of a DVB
 
Figure 8.2: Scheme of a DVB-T transmission system.
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(STB). Allowed bitrates for the transported data depend on a number of coding and 
modulation parameters: it can range from about 5 to about 32 Mbps. 
• Splitter: two different TSs can be transmitted at the same time, using a technique 
called Hierarchical Transmission (HT). It may be used to transmit, for example, a 
standard definition SDTV signal and a high definition HDTV signal on the same carrier. 
Generally, the SDTV signal is more robust than the HDTV one. At the receiver, 
depending on the quality of the received signal, the STB may be able to decode the 
HDTV stream or, if signal strength lacks, it can switch to the SDTV one. 
• MUX adaptation and energy dispersal: the MPEG-2 TS is identified as a sequence of 
data packets, of fixed length (188 bytes). With a technique called energy dispersal, 
the byte sequence is decorrelated.  
• External encoder: a first level of error correction is applied to the transmitted data, 
using a non-binary block code, a Reed-Solomon RS (204, 188) code, allowing the 
correction of up to a maximum of 8 wrong bytes for each 188-byte packet.  
• External interleaver: convolutional interleaving is used to rearrange the transmitted 
data sequence, in such a way that it becomes more rugged to long sequences of 
errors.  
• Internal encoder: a second level of error correction is given by a punctured 
convolutional code, which is often denoted in STBs menus as FEC (Forward error 
correction). There are five valid coding rates: 1/2, 2/3, 3/4, 5/6, and 7/8.  
• Internal interleaver: data sequence is rearranged again, aiming to reduce the 
influence of burst errors. This time, a block interleaving technique is adopted, with a 
pseudo-random assignment scheme.  
• Mapper: the digital bit sequence is mapped into a base band modulated sequence of 
complex symbols. There are three valid modulation schemes: QPSK, 16-QAM, 64-
QAM. 
• Frame adaptation: the complex symbols are grouped in blocks of constant length 
(1512, 3024, or 6048 symbols per block). A frame is generated, 68 blocks long, and a 
superframe is built by 4 frames.  
• Pilot and TPS signals: in order to simplify the reception of the signal being 
transmitted on the terrestrial radio channel, additional signals are inserted in each 
block. Pilot signals are used during the synchronization and equalization phase, while 
TPS signals (Transmission Parameters Signalling) send the parameters of the 
transmitted signal and to unequivocally identify the transmission cell. The receiver 
must be able to synchronize, equalize, and decode the signal to gain access to the 
information held by the TPS pilots. Thus, the receiver must know this information 
beforehand, and the TPS data is only used in special cases, such as changes in the 
parameters, resynchronizations, etc.  
• OFDM Modulation: the sequence of blocks is modulated according to the OFDM 
technique, using 2048, 4096, or 8192 carriers (2k, 4k, 8k mode, respectively). 
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Increasing the number of carriers does not modify the payload bit rate, which 
remains constant.  
• Guard interval insertion: to decrease receiver complexity, every OFDM block is 
extended, copying in front of it its own end (cyclic prefix). The width of such guard 
interval can be 1/32, 1/16, 1/8, or 1/4 that of the original block length. Cyclic prefix is 
required to operate single frequency networks, where there may exist a not 
eliminable interference coming from several sites transmitting the same program on 
the same carrier frequency.  
• DAC and front-end: the digital signal is transformed into an analog signal, with a 
digital-to-analog converter (DAC), and then modulated to radio frequency (VHF, UHF) 
by the RF front-end. The occupied bandwidth is designed to accommodate each 
single DVB-T signal into 5, 6, 7, or 8 MHz wide channels. 
 
8.1.3 Multimedia Home Platform 
The Multimedia Home Platform (MHP) defines a generic interface between interactive 
digital applications and the terminals on which those applications execute. It enables digital 
content providers to address all types of terminals ranging from low-end to high-end set-top 
boxes, integrated digital TV sets and multimedia PCs. The MHP extends the existing, 
successful DVB open standards for broadcast and interactive services in all transmission 
networks [MHP, 2008]. 
 
8.1.3.1 MHP Architecture 
The architecture of the MHP is defined in terms of three layers: 
• resources; 
• system software 
• applications.  
 
 
Figure 8.3: MHP architecture. 
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Typical MHP resources are MPEG processing, I/O devices, CPU, memory and a graphics 
system. The system software uses the available resources in order to provide an abstract 
view of the platform to the applications.  
AppIications include an application manager (also known as a "navigator") to control the 
MHP and the applications running on it. 
 
8.1.3.2 MHP System Core 
MHP is based around a platform known as DVB-J, which includes a virtual machine as 
defined in the Java Virtual Machine specification from Sun Microsystems. A number of 
software packages provide generic application program interfaces (APIs) to a wide range of 
features of the platform. MHP applications access the platform only via these specified APIs. 
MHP implementations are required to perform a mapping between these specified APIs and 
the underlying resources and system software. 
 
8.1.3.2 MHP Profiles 
The MHP specification provides a consistent set of features and functions required for the 
Enhanced Broadcast, Interactive Broadcast and Internet Access profiles.  
 
Figure 8.4: MHP profiles. 
 
The Enhanced Broadcast profile is intended for broadcast (one way) services, while the 
Interactive Broadcast profile supports additional interactive services. The Internet Access 
profile allows MHP to use the worldwide communication network provided by the Internet. 
 
 
 8.1.4 JavaTV Xlet
JavaTV API are an extension of the Java platform designed for developers who are producing 
Java-based interactive television content. The Java TV API gives programs written in the Java 
programming language control of broadcast television receivers and set
 
An Xlet is a JavaTV application that follows a lifecycle model defined by a specific finite state 
machine (Fig. 8.5) [Calder et al., 2000]
Figure 8.5: Xlet lifecycle model.
 
In the Loaded state the Xlet has been loaded by the broadcaster in the set
yet uninitialized. From here, it can be initialized or 
Paused state the Xlet is initialized and waits to become 
the required operations.  
 
8.1.5 DSM-CC Object Carousel
Interactive TV generally consists of small applications, typically java applications, which 
transmitted together with the A/V content in a transport stream. The application files are 
carried in the transport stream in a Digital Storage Media
Object Carousel [Borko et al., 1995
the transmission of objects from a server to a client. The objects are transmitted in cycles, 
such that a client can connect to the transmission and receive all the objects
need for a hack channel from the client to the serve
channel in the middle of a program, so the files for any interactive application have to be 
repeated frequently in the transport stream. Besides transmitting files the Object Carousel is 
also used to transmit three 
objects. The directory objects convey the file system structure information, so the names of 
the files and the directory structure. The Stream objects allow the broadcaster to send A
related commands like pause, play and stop. Stream event objects are used to ca
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information of the Stream event descriptors in the stream. Stream event descriptors are 
used to provide a mechanism whereby the interactive application can respond to “events” in 
the A/V content. 
 
8.2 Others Tele-Home Care Projects in 
Literature 
The primary activity of telemedicine systems was the transmission of diagnostic medical 
images using television for medical consultation from physician to physician in remote 
places. Recently, telemedicine systems through the Internet via satellite have become a 
reality by means of high throughput mixed satellite-web communication channels. This 
section presents some home-oriented telemedicine projects making use of DVB and 
Internet, without the claim to be exhaustive. 
 
The Interactive Satellite Multimedia Information System (ISIS) project [Pierucci et al., 2000], 
realized a telemedicine system based on satellite communication for furnishing interactive 
services for residential users together with the traditional TV distribution, porting tipical 
applications developed for terrestrial network (Internet) to the satellite digital video 
broadcasting technology (DVB-S). By a dual-band terminal, connected in uplink via Eutelsat 
satellite and in downlink via the Italsat satellite, the ISIS system provides a small and low-
cost transceiver for sites not connected to the Internet or connected only in dial-up low-
speed mode (Fig. 8.6). Through his Java application for the DVB-S transceiver, called Medical 
Environment for Diagnostic Images (MEDI), the project can manage a medical image 
database for remote expert consultation and so it demonstrated the feasibility of satellite-
based interactive multimedia services for telemedicine 
purposes. 
 
Figure 8.6: ISIS architecture scheme. 
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In 2001, a multipurpose health care telemedicine system with a base unit and a mobile unit 
was developed in Greece too [Kyriacou et al., 2001]. At patient’s home, the mobile unit 
allows the transmission of vital bio-signals and static images of the patient to the base unit 
at the physician site (office or hospital). The mobile unit device is compliant with some of the 
commercial main vital signs monitor and it is able to transmit ECGs, non-invasive blood 
pressure (NIBP), body temperature, percentage of arterial oxygen saturation (SpO2) and 
heart rate. Based on the TCP/IP protocol, the communication between the two parts ensures 
safe data transmission and the possibility to use different telecommunication means (GSM 
or satellite links) (Fig. 8.7). 
 
 
Figure 8.7: Kyriacou’s architecture scheme. 
 
Launched in January 2001, the Universal Remote Signal Acquisition For hEalth (U-R-Safe) 
tele-home care project [Mailhes et al., 2003], created a mobile telemedicine system for 
home monitoring to be used by elderly peaple and disabled patients in Europe. Via short 
range Wireless Personal Area Network (WPAN), wearable ECG and SpO2 sensors are 
connected to a portable electronic device, able to send the recorded data to a remote 
central through the TCP/IP protocol and the wireless public network (GPRS, UMTS and GEO 
satellites). The portable unit is also capable of sending an alarm when patient fells sick, falls 
or pushes a button (Fig. 8.8). 
 
 Figure 8.8: U-R-Safe architecture scheme.
 
The Standard and Interoperable Satellite Solution
Area (HEALTHWARE) project [Loghelongue, 2007]
and Space thematic priority of the 6th Framework Program
telecommunications systems and
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validating DVB-RCS based telemedicine solutions. It will focus on the areas
respiratory disease, cardiology and oncology,
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Figure 8.9: HEALTHWARE architecture scheme.
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Even if these systems are very interesting, none of them owns the possibility to be used by 
untrained people to perform single exams rather then continuous monitoring, with an 
immediate visual confirmation of the quality of the signal measurement. None of them could 
be used by the patient to control his/her health state through simple measurements even 
without sending the exam to a remote care center. 
 
8.3 System Overview 
This system is conceived to keep as low as possible the costs of the extra hardware with 
respect to a minimum setup composed of a TV and a DVB-T set-top box connected to the 
telephone line. This way the usability by untrained people not accustomed to digital 
equipments but the TV set one is also preserved. A global representation of the entire 
system is depicted in Fig. 8.10. 
 
Figure 8.10: The main parts of the DVB-T based tele-home care realized system. 
 
At the patient’s home, the TV set is equipped with a standard interactive set-top box. 
Standard Multimedia Home Platform (MHP) set-top boxes are simple computers with their 
Operating System, a Java Virtual Machine and a set of standard ports for I/O interfacing, 
such as a smart card reader and an internal 56Kbps modem for pay-per-view services. From 
the patient’s point of view, the system exploits the remote control of the set-top box as 
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control input for the user, the TV screen as output for him, and the telephone line to send 
the data to a Remote Data Base (RDB). For this work, has been used a Telesystem TS7.4DT 
set-top box, with the version 21p1 of the real-time Operating System (i.e. Osmosys) and 
implementing the MHP 1.02 profile with some enhancements, primarily the addition of java 
packages for both the smart card and the internal modem management. 
 
The interactive application (Java Xlet) is loaded on the patient’s set-top box through an ether 
broadcast DVB-T transmission, while the user is watching the broadcaster’s channels. It can 
run in the set-top box thanks to the Java Virtual Machine. The Xlet mainly manages the 
acquisition and transmission to the Remote Data Base of the patient’s data, but also enables 
the visualization on the TV screen of the physician’s feedbacks from the Remote Hospital. To 
allow a secure one-to-one sensitive data transmission in a one-to-many communication 
channel, like in DVB-T broadcasting, a double key encrypting technique is implemented. In 
such a way, patients can view and read just their physician’s messages. 
 
A microcontroller-based custom Smart Card (SC), which is programmed by the Remote 
Hospital, allows an easy use of the system, providing all the necessary data to the Xlet to 
configure the framework for a specific patient. The SC stores the patient’s name and their 
personal identification code, the treating physician’s name and their identification number, a 
permission exam code, some information about the Internet Service Provider for the 
Internet access (user ID, password, telephone number), the Remote Data Base IP address 
and the private key needed to read the physician’s feedback. This way the patient does not 
have to remember any code, number, password, and different patients can share the same 
hardware platform simply inserting their personal smart card. According to the international 
recommendations about the patent’s safety, the SC also provides the Xlet with the data 
exams collected by the acquisition unit (the Base Station) through a wireless link at 2.4GHz in 
the free ISM band. Fig. 8.11 shows the picture of the first prototype of the realized custom 
smart card. It is build around a low-cost microcontroller connected through the SPI protocol 
with a Mi-Wi P2P compliant wireless transceiver. 
 
 
Figure 8.11: First prototype of the custom smart card. 
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The Base Station (BS) enables the acquisition of some physiological parameters needed for 
the monitoring of diabetic and cardiopatic patients (i.e. blood pressure, heart rate, body 
temperature, body weight and glycemia) through wired serial RS232 compliant connections 
to three commercial and certificate biomedical devices (i.e. Menarini Glucocard G+ 
glucometer, OMRON 705IT sphygmomanometer and A&D UC-321P personal precision 
electronic body scale). It is important to notice that the BS could communicate with others 
biomedical devices, depending on the application scenario. To improve patient’s safety, the 
BS is battery-powered and communicates with the Xlet running on the set-top box through a 
wireless link with the SC. In this way, the DVB-T equipment and the acquisition unit are 
wireless coupled, improving patient’s safety. From the patient’s point of view, the BS is only 
a black box with a very simple user interface: the patient has only to connect the commercial 
biomedical device to the BS and press a big button. From this point, the Xlet will do all the 
necessary to send the acquired data to the Remote DB. The SC and BS units are conceived 
taking into account the low-cost target, then resorting to a very simple and low-cost 
microcontroller, i.e. the Microchip PIC18F4620. Based on a 8-bit 10 MIPS RISC CPU, it has 
64KB of Flash memory, 4KB of RAM, 1KB of EEPROM, a hardware multiplier, 13 channel 10-
bit ADC, an USART module and a SPI/I2C controller. The wireless module used in the SC and 
in the BS is based on the Microchip MRF24J40 transceiver at 2.4GHz with a built-in ZigBee 
and Mi-Wi protocol stack.  
 
Exploiting the full potential of the DVB-T technology and of the Java Xlet application loaded 
on the patient’s set-top box, after the acquisition of the physiological parameters of interest, 
the uplink connection supported by the set-top box is used to send the exam results to a 
Remote DB for physician analysis.  
 
At the Remote Hospital, only a simple PC acting as a TCP/IP client is needed. Through the 
Internet, the physician can browse into the patient’s data for clinical examination and can 
send feedbacks directly to a specific patient using the DVB-T channel through a secure 
Internet connection with the broadcasting station.  
 
As a matter of fact, we are testing the system on the field in cooperation with a local DVB-T 
broadcaster (i.e. VIDEOLINA [VIDEOLINA]) but for our preliminary tests we also developed 
the broadcasting part. Our DVB-T broadcast system is based on the CreaTV MiniLab by 
Media Solution (Fig. 8.12). Through the JustDvb-It 2.0 software, video and audio MPEG-2 
encoded contents are multiplexed together with the Xlet application to build the Single 
Program Transport Stream (SPTS) to broadcast. A PCI card DekTec DTA-110, a multistandard 
modulator with UHF Upconverter, is coupled with a 20 dBm RF amplifier (RFbay LPA-4-14) 
for the ether transmission of the SPTS. To establish the bit rate needed to encode audio, 
video and multimedia contents in the MPEG-2 format, it is necessary to know the coding and 
modulation parameters used to transmit the SPTS. We have chosen 1/2 for the 
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convolutional rate, 16QAM for the modulation type and 1/4 of the original block length for 
the guard interval. The resulting bit rate is 9953 Kbps.  
 
Figure 8.12: The block diagram of our broadcast transmission system. 
 
Once the Xlet has been loaded on the set-top box, it starts to read the data stored in the SC. 
Without any valid smart card identification the application cannot proceed. The permission 
exam code stored in the SC is used to allow the patient to perform only some specific exams 
among those available, hence disabling all the other ones. For example, Figure 3 shows a 
screenshot of the Xlet sending two acquired glucometer measurements to the Remote DB. A 
small area on the top-right corner of the Xlet is devoted to the background TV program 
streaming. A pop-up window alerts the patient if he/she is exiting the Xlet without sending 
the results to the RDB (in this case the exam results will be lost). 
 
 
Figure 8.13: Picture of the Xlet sending two acquired glucometer measurements to the RDB. 
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8.4 Overview of the First Version of the 
System  
The first architecture of the system at patient’s home is depicted in Fig. 8.14. 
 
 
Figure 8.14: Architecture of the first version of the system at patient’s home. 
  
In this version of the system, the smart card is used only to identify the patient providing all 
the information needed to carry out the proper exams, whereas the biomedical parameters 
feed the Xlet (called MHPHomecare) through the serial RS-232 port (present only in set-top 
boxes upgradable). 
 
The microcontroller-based Base Station  is controlled by the Xlet and by the user through the 
set-top box remote control. 
 
8.4.1 Patient’s User Interface 
In this first version, the graphic user interface (GUI) of the Xlet (hereafter called 
MHPHomecare) allow the patient to easily control the acquisition process by means of the 
remote control. The user can explore the application moving through the different full-
screen frames (hereafter called FSFs), choosing among the possible options and functions by 
means of the remote control keys, as if it would be a PC keyboard. 
 
Three of the full-screen frames are generic whilst there is another FSF for each exam. The 
three generic FSFs are: 
• the primary FSF, the first FSF shown when the application is started. It waits for the 
smart card insertion in the set-top box for user authentication and then it shows the 
patient’s name (storing the other authentication data only for the transmission 
purposes), waiting for patient’s commands (Fig. 8.15); 
• the about FSF, that shows the application credits; 
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• the reduced FSF, that corresponds to the window minimization to allow the patient 
to watch a TV program while the application is running in background. 
 
 
Figure 8.15: Primary FSF. 
 
8.4.2 The First Prototypal Base Station 
A simple 3-lead ECG is used to test the whole system, so there is only another FSF (a 
screenshot of this FSF is shown in Fig. 8.16), called ECG exam. The ECG Exam FSF enables the 
ECG acquisition and shows in real-time the samples acquired from the Base Station and all 
the other information sent by it about the current exam, such as the hearth rate (in bpm) 
and a warning message in case of poor quality signal. Once the exam has been saved, from 
the same FSF it is possible to send it to the server of the RCC, to review it on the TV (with 
zoom and scroll functions), to save a new exam or to return to the primary FSF.  
 
 
Figure 8.16: The ECG exam screen of the MHPHomecare application (ECG Exam FSF).  
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The three channel electrocardiogram consists in a classical ECG amplifier coupled with a very 
simple and low cost Digital Signal Controller (DSC), i.e. the MicrochipTM dsPIC30F4013 (Fig. 
8.17). This is a 16-bit 30MIPS DSC enhanced with DSP hardware, such as a 17-bit x 17-bit 
multiplier, a 40-bit ALU, two 40-bit saturating accumulators and a 40- bit bidirectional barrel 
shifter. It also provides several embedded peripherals such as a 12-bit successive 
approximation analog to digital converter, and an USART, both of them employed in this 
prototype. 
 
 
Figure 8.17: A schematic representation of the lead-I for the prototipal 3-lead ECG base 
station. 
 
The fundamental characteristics of the Base Station (frequency bandwidth, sampling 
frequency and the number of bits of the A/D converter) are chosen according to the 
recommendations of American Heart Association for standardization and specifications in 
automated electrocardiography [Bailey et al., 1990]. The ECG amplifier is a low-pass system 
with a variable gain up to 2000 and a cutoff frequency of 100 Hz. It consists of an optically 
isolated instrumentation amplifier with high CMRR connected to the wrists of the patient 
and a simple inverting operational amplifier connected to the right ankle for electromagnetic 
coupling noise rejection purpose, so that only 3 disposable (or reusable) electrodes are 
needed. The DSC is programmed to sample the ECG signal at 250 Hz, and it is interfaced 
through its internal USART to the DVB-T set-top box. According to the international 
recommendations about the patient’s safety, the physical connection between the Base 
Station and the set-top box is represented by an infrared (IR) link. The Base Station embeds a 
 module for the IR transmission of the serial stream, whereas the set
external IR coupler connected to the RS
 
Figure 8.18: A screenshot of the p
adapter (right). 
 
In order to reduce both the residual 50/60 Hz environmental electrical noise 
implemented a digital notch filter, whereas a high
0.05 Hz) was added for the baseline drift elimination
performed in real-time on the Base Station, since the set
due to the Java VM and to the applications running on it. 
 
Figure 8.19: Results of the digital notch filter 
signal acquired by the prototypal base station
 
 
-top box exploits an 
-232 serial port (Fig. 8.18).  
    
rototipal 3-lead ECG base station (left) and RS
-pass digital FIR filter (cutoff frequency 
 (Fig. 8.19). All these computations are 
-top box is quite slow in 
 
   
(left) and of the high-pass filter 
. 
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-232 to IR 
the base station 
processing 
 
(right) on ECG 
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On the Base Station has been also implemented a simple QRS detector algorithm based on 
amplitude and first derivative (section 2.2.1.6.1) for heart rate calculation and visualization 
on the TV screen. The RR interval measurement is performed sample by sample, and if it is 
too far from the standards a warning code is sent to the set-top box to ask the user to 
control the correct connection of the electrodes. The average heart rate is sent when the 
acquisition stops and is referred to the average RR during the acquisition window. 
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Chapter 9 
 
Concluding Remarks 
 
 
 
 
 
 
 
 
 
 
Most of the interventions to prevent and treat diabetes and cardiovascular diseases 
significantly affect the use of health services. Therefore, more effective and cheaper ways to 
prevent the major complications of diabetes and CVD are needed.  
 
Diabetes and CVD care through blood pressure control is cost saving mainly because of its 
large health benefits and relatively low intervention costs. The National Health Service 
argues strongly that newer systems of care and newer ways of thinking are needed to tackle 
complex diseases such as diabetes and CVD.  
 
The need to know the long-term effects of diabetes diseases on CVD has inclined to develop 
new system and biomedical devices for non-invasive and remote monitoring/screening of 
blood glucose and other parameters related to prediabetes, diabetes, sleep apnoea, heart 
attack, atrial fibrillation and deep vein thrombosis. 
 
The developed wearable device, battery-powered for patient’s safety, allows the continuous, 
real-time monitoring of some cardiovascular disorders, and can trigger an alarm if the state 
of the disorder can be considered dangerous. It is easy to wear and easy to use, thanks to its 
reduced dimensions and the long term battery autonomy. Moreover, through a wireless link 
with an internet module, the wearable device allows a long time continuous monitoring by a 
remote monitoring station, which can alert the physicists in case of dangerous situations. 
Thanks to the comfortable standard SpO2 sensor applied in one of the fingers, the device 
can be applied to the continuous monitoring of sleep apnoea through HRV analysis, 
continuous monitoring of blood pressure through a hydrostatic calibration of PPG signal, and 
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can aid physicians to the treatment of anticoagulant oral therapy of patients with heart 
attack through a wavelet analysis of the PPG wafeforms. 
 
The presented tele-home care system, based on a framework built around the well 
established DVB-T platform, allows remote monitoring of the patients conditions directly 
from their home, without any installation procedure. After 2012, DVB-T will be the only 
terrestrial television system in Europe, so its diffusion will be capillary, at a very low cost for 
the final user. Exploiting low-cost technologies for the acquisition unit will then lead to the 
development of a user-friendly cheap solution for tele-home care. Some strong points of the 
proposed system are: 
• low-cost, since beyond the TV set only a low cost microcontroller-based acquisition 
unit and a custom wireless smart card are required; 
• user-friendly interface, also for elderly people accustomed to TV but not to 
computers; 
• flexibility, since the functionality of the system can change exploiting the same 
platform; 
• easy maintainability, since Xlet broadcasting enables upgrade, and the smart card 
improves usability and completely avoids any installation activity at the patient’s 
home. 
The overall system has been implemented, tested and is currently used for some trials on 
the field by twenty 65 years old in average selected diabetic and cardiopathes patients. At 
the end of the trial period, each patient will fill a standard questionnaire (i.e. QUEST, Quebec 
User Evaluation of Satisfaction with assistive  Technology) in order to evaluate patient’s 
satisfaction and the related services he/she experienced. 
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